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SCIENTIFIC OPINION 
Scientific Opinion on the evaluation of the safety and efficacy of 
peroxyacetic acid solutions for reduction of pathogens on poultry carcasses 
and meat1 
EFSA Panel on Biological Hazards (BIOHAZ)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
This scientific output, published on 13 June 2014, replaces the earlier version published on 26 March 2014*. 
ABSTRACT 
Studies evaluating the safety and efficacy of solutions, containing peroxyacetic acid (PAA) as the active 
ingredient, in mixtures with acetic acid, hydrogen peroxide, and 1-hydroxyethylidene-1,1-diphosphonic acid 
(HEDP) and possibly octanoic acid and peroxyoctanoic acid, for reduction of pathogens on poultry carcasses and 
meat were assessed. Treatments at ambient temperature consisted of dipping in short term baths, in chiller baths 
or spraying. On the basis of the previous EFSA exposure scenarios including short term baths that were not 
evaluated previously, no toxicity concerns were identified with regard to residues of peroxyacids, to HEDP and 
to possible reaction products of hydrogen peroxide and peroxyacids with lipids and proteins of the poultry 
carcasses. A relevant reduction of PAA treatment on E. coli and coliforms was demonstrated by dipping warm 
carcasses, but few data were available for pathogens (Salmonella and Campylobacter). Spraying appeared to be 
less effective than dipping in reducing indicator organisms than dipping. When dipping chilled carcasses, 
reduction of indicator organisms and pathogens was evident, although only in low or medium strength of 
evidence studies. In chiller bath application, there was a relevant impact on E. coli, but less effect on coliforms, 
and little data was available on reduction of pathogens. The emergence of acquired reduced susceptibility to 
biocides and/or resistance to therapeutic antimicrobials following the use of PAA was considered unlikely. There 
were no concerns for environmental risk of peroxyacids, acetic acid and octanoic acid. On the basis of a 
conservative preliminary guideline for surface water quality, the emission of HEDP from a poultry plant into the 
environment could not be considered safe a priori. It was recommended that HACCP plans should include 
monitoring of the concentration of HEDP and of the decontaminating substance in the working solution and 
post-marketing surveillance for resistance in both pathogenic and commensal bacteria. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the Panel on Biological Hazards (BIOHAZ 
Panel) and the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF 
Panel) were asked by the European Food Safety Authority (EFSA) to deliver a Scientific Opinion on 
an application dossier submitted by the U. S. Department of Agriculture (USDA) for the approval of 
peroxyacetic acid solutions intended to be used by food business operators during processing for the 
reduction of pathogens on poultry carcasses and meat. 
EFSA was requested to evaluate the safety and efficacy of peroxyacetic acid solution intended to be 
used by food business operators during processing for the reduction of pathogens on poultry carcasses 
and meat, considering i) the toxicological safety of the substance; ii) the efficacy, i.e. does the use of 
the substance significantly reduce the level of contamination of pathogens on poultry carcasses and 
meat; iii) the potential emergence of reduced susceptibility to biocides and/or resistance to therapeutic 
antimicrobials linked to the use of the substance; iv) the risk related to the release of the processing 
plant effluents, linked to the use of the substance, into the environment. 
Approval was sought for reduction of surface contamination of raw poultry carcasses and poultry meat 
by the use of an aqueous solution containing peroxyacetic acid (PAA) as the active ingredient. The 
solution also contains acetic acid and hydrogen peroxide, and 1-hydroxyethylidene-1,1-diphosphonic 
acid (HEDP) as a product stabilizer. In some mixtures, octanoic acid is added, functioning as a 
surfactant. 
The Applicant applied for PAA being used 1) on warm eviscerated carcasses or parts (pre-chill); (2) 
on carcasses in chiller baths (chill); (3) on chilled carcasses or parts (post-chill). PAA can be applied 
as spray washing or dipping depending on the step in the processing line. The in-use concentration of 
the active ingredient is not to exceed 2 000 ppm in the short term baths (3 minutes), and up to 230 ppm 
in the long duration chiller baths (duration of exposure during chilling can be 1-2 h). The 
concentration in spray washes is typically 400-700 ppm, applied for 10 seconds. The maximum 
temperature is ambient temperature and pH of a 600 ppm solution is approximately 2.5. It is not 
intended to subsequently remove the PAA solution from the poultry carcasses or poultry meat. PAA is 
highly reactive and, when used in the presence of organic compounds, dissociates very rapidly and 
loses antimicrobial properties. PAA breaks down to acetic acid and water and the mixtures are not 
recycled.  
Concerning the toxicological safety, on the basis of the previous EFSA exposure scenarios, which 
included all uses described in the present application, except for the short term bath (< 3 minutes), no 
toxicity concerns were identified with regard to residues of peroxyacids. This is due to the described 
high instability of the compound, including the use of the short term high concentration bath. No 
concerns are indicated with respect to residues of acetic acid and octanoic acid, respectively, again 
including the short term use of a high concentration bath. With regard to the product stabilizer HEDP, 
no safety concern was identified with regard to the high concentration bath since for HEDP, a margin 
of safety ranging from 3 420 to 43 103 can be calculated against a No Observed Adverse Effect Level 
(NOAEL) of 50 mg/kg bw/day obtained in rat and rabbit reproductive toxicity studies, although there 
is some uncertainty as to the validity of the NOAEL used. Regarding the question of the safety of 
possible reaction products of hydrogen peroxide and peroxyacids with lipids and proteins/amino acids 
of the poultry carcasses, it was concluded that no risk was expected because of the low amino acid 
content in the carcass surface, including the short term treatment at higher peroxide concentrations. 
With regard to lipid peroxidation, no by-products were identified in producer experiments referred to 
in the previous risk assessment, when using immersion for 60 minutes in 200 mg/L total peroxyacetic 
acid. On this basis, the short term high concentration bath scenario included in the present application 
is not expected to cause measurable lipid peroxidation. 
The application dossier included eight peer-reviewed published papers, one conference proceeding and 
15 reports with data of in-house studies for consideration in evaluating the efficacy of PAA solution in 
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poultry meat decontamination. All papers, except the conference proceeding and four in-house studies 
were considered in the evaluation of the efficacy. The studies submitted by the Applicant used a wide 
range of experimental designs and thus differed in relation to products, settings, method of application, 
PAA concentration, use of controls, microorganisms studied, time of analysis after application, etc. All 
these parameters impacted on the observed efficacy. Comparison beyond treatment groups was 
therefore not possible. Studies were classified as of high or medium strength of evidence if they used 
naturally-contaminated samples on industrial or pilot scale, respectively.  
Reduction of bacterial counts was considered relevant if the confidence interval of the mean decimal 
reduction and of the relative prevalence reduction did not include 0 (statistically significant), or, 
following expert judgement (when confidence intervals were not available), if the mean decimal 
reduction was greater than 0.5 log-units. There was consistent evidence for a relevant impact (1-3 log-
units over untreated controls) of PAA treatment on E. coli and coliforms when treating warm carcasses 
by dipping. There were few data on reduction of pathogens for this treatment. Spraying of warm 
carcasses appears to be less effective in reducing indicator organisms than dipping (0.5-1.5 log-units). 
There is consistent evidence for a relevant reduction (0.5-2 log-units) of indicator organisms and 
pathogens when treating chilled carcasses or parts by dipping, but the studies were of low or medium 
strength of evidence.  
When adding PAA to chiller baths, a relevant impact of PAA treatment on E. coli (0.5-2 log-units) 
was registered, whereas the effects on coliform bacteria were less consistent. There were few data on 
reduction of the number of pathogens for this treatment. The Salmonella prevalence was reduced in 4 
out of 5 studies of high strength of evidence. The efficacy of PAA treatment after storage was only 
investigated in two studies with naturally-contaminated samples, and these gave conflicting results. 
Such studies are required in the EFSA guidelines to evaluate whether micro-organisms are truly 
inactivated or only sublethally injured. 
On the basis of the history of safe usage information provided by the Applicant, it was concluded that 
the emergence of acquired reduced susceptibility to biocides and / or resistance to therapeutic 
antimicrobials following the use of PAA is unlikely. 
There is no concern about environmental toxicity of acetic acid and octanoic acid which are 
effectively neutralized before discharge of wastewater. Likewise, tests regarding development and 
dissemination of acquired reduced susceptibility of environmental microorganisms are therefore not 
considered necessary. On the basis of a conservative preliminary guideline for surface water quality 
from a literature review, the emission of HEDP from a poultry plant including via a wastewater 
treatment system into the freshwater environment cannot be considered safe a priori. Site-specific 
considerations related to dilution factors and improved efficiency of wastewater treatment plants can 
mitigate the possible environmental risk associated with the emission of HEDP from individual 
poultry plants using PAA solutions for decontamination treatment. 
It is recommended that HACCP plans should include: i) monitoring of the concentration of HEDP in 
the working PAA solution in order to control residues of HEDP on poultry carcasses (a method for the 
determination of HEDP residues on poultry carcases should be developed and validated); ii) 
monitoring of the concentration of the decontaminating substance in the working PAA solution; iii) 
post-marketing surveillance for resistance in both pathogenic and commensal bacteria if PAA is 
applied for decontamination of poultry carcasses. Laboratory studies should be undertaken to confirm 
that reduced susceptibility to biocides and/or resistance to therapeutic antimicrobials following the use 
of PAA does not occur. Furthermore, in order to support the assessment of efficacy, treated carcasses 
should also be examined at the end of shelf life, to ensure that the level of contamination remains low. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The EU food hygiene legislation is aimed at protecting consumers against potential risks to health 
and maintaining a high level of consumer protection at all stages of the food chain. This objective 
must be achieved by applying the appropriate measures, including good hygiene practices and 
hazard control measures at each step of the food chain. 
According to EU scientific advice4, decontamination practices can constitute a useful tool in 
further reducing the number of pathogenic microorganisms but the use of substances intended to 
remove microbial surface contamination should only be permitted if a fully integrated control 
programme is applied throughout the entire food chain. Those substances shall be assessed 
thoroughly before their use is authorised. 
Article 3 (2) of Regulation (EC) No 853/2004 provides a legal basis to approve, and therefore 
authorise, the use of substances other than potable water to remove surface contamination from 
products of animal origin. 
In addition to the safety of the substance, are also a matter of concern the potential emergence of 
reduced susceptibility to biocides and/or resistance to therapeutic antimicrobials and the impact of 
the substance or its by-products on the environment. 
Therefore, before taking any risk management decisions on their approval, a risk analysis process 
should be carried out taking into account the results of a risk assessment based on the available 
scientific evidence and undertaken in an independent, objective and transparent manner. 
EFSA GUIDANCE AS PROVIDED BY THE EUROPEAN COMMISSION 
On 14 April 2010, the European Food Safety Authority (EFSA) issued a revision of a guidance 
document (EFSA Panel on Biological Hazards (BIOHAZ), 2010) on the submission of data for the 
evaluation of the safety and efficacy of substances for the removal of microbial surface contamination 
of foods of animal origin intended for human consumption. 
APPLICATION FOR APPROVAL AS PROVIDED BY THE EUROPEAN COMMISSION 
On 15 May 2013, the Commission received an application dossier from the U. S. Department of 
Agriculture (USDA) for the approval of peroxyacetic acid solution intended to be used by food 
business operators during processing for the reduction of pathogens on poultry carcasses and 
meat. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested to evaluate the safety and efficacy of peroxyacetic acid solution intended to be 
used by food business operators during processing for the reduction of pathogens on poultry 
carcasses and meat, considering: 
 the toxicological safety of the substance; 
 the efficacy, i.e. does the use of the substance significantly reduce the level of contamination of 
pathogens on poultry carcasses and meat; 
 the potential emergence of reduced susceptibility to biocides and/or resistance to therapeutic 
antimicrobials linked to the use of the substance; 
                                                     
4  SCVPH (Scientific Committee On Veterinary Measures Relating To Public Health), 1998. Report on the benefits and 
limitations of antimicrobial treatments for poultry carcasses, 30 October 1998; SCVPH (2003) Opinion on the evaluation 
of antimicrobial treatments for poultry carcasses (http://ec.europa.eu/food/fs/sc/scv/out14_en.pdf ). 
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 the risk related to the release of the processing plant effluents, linked to the use of the substance, 
into the environment. 
APPROACH TAKEN TO ANSWER THE TERMS OF REFERENCE 
In order to assist in assessing the safety and efficacy of a proposed decontaminating agent of foods of 
animal origin, EFSA issued in 2010 a revised guidance document titled “Revision of the joint 
AFC/BIOHAZ guidance document on the submission of data for the evaluation of the safety and 
efficacy of substances for the removal of microbial surface contamination of foods of animal origin 
intended for human consumption” (EFSA Panel on Biological Hazards (BIOHAZ), 2010). The 
document presents the major components and data that an application dossier should contain. These 
guidelines, terminology and procedure have been used in this Scientific Opinion for the assessment of 
peroxyacetic acid solution for use in the reduction of pathogens on poultry carcasses and meat. 
After having received this request from the European Commission, EFSA assigned the mandate to the 
Panel on Biological Hazards (BIOHAZ Panel; leading Panel) and the Panel on Food Contact 
Materials, Enzymes, Flavourings and Processing Aids (CEF Panel). Chapters 2 and 5, and the 
respective conclusions were endorsed by the CEF Panel by written procedure on 28 February 2014. 
The term “poultry carcasses and meat” is defined as carcasses and/or skin-on parts from poultry, 
including chicken.  
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ASSESSMENT 
1. Introduction 
Approval was sought for reduction of surface contamination of raw poultry carcasses and poultry meat 
by the use of an aqueous solution containing peroxyacetic acid as the active ingredient. The solution 
also contains acetic acid and hydrogen peroxide, and 1-hydroxyethylidene-1,1-diphosphonic acid 
(HEDP). The latter is added to prevent the breakdown of peroxyacetic acid and hydrogen peroxide by 
chelating metal ions. In some cases octanoic acid is added, functioning as a surfactant, and 
peroxyoctanoic acid is formed. The mixture will be referred to as PAA stock solution, no matter 
whether or not octanoic acid is present. Typical compositions of the mixtures are given in Table 1. 
The PAA stock solution is prepared by mixing acetic acid, hydrogen peroxide, water, and octanoic 
acid if applicable. The reaction is allowed to continue for up to 10 days in order to increase product 
yield. 
Table 1:  Composition by weight (%) of peroxyacid mixtures, as provided by the Applicant 
Component Formula 1 Formula 2 Formula 3 
Acetic acid 40.6 45 35 
Peroxyacetic acid 12.0 20 15 
Hydrogen peroxide 6.2 6.0 10 
Water 36.6 29 39 
1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) 0.8 0.1 < 1.0 
Octanoic acid 3.2   
Peroxyoctanoic acid 1.4   
 
Depending on the mode of application, the PAA stock solution is to be diluted on-site to a 
concentration of peroxyacetic acid in potable tap water for use as a decontaminating treatment for raw 
poultry carcasses or poultry meat. 
Relative to the purpose of the treatment, the dossier indicates: “PAA will be used to reduce the 
incidence of foodborne illness by decreasing the numbers of human pathogens on poultry carcasses or 
parts provided to consumers. While not a primary objective, the use of PAA may also reduce the 
numbers of spoilage organisms and may increase the storage life of chilled poultry carcasses and 
parts”. A description is given about the presence of Salmonella and Campylobacter on broiler 
carcasses in the EU and the disease burden of human salmonellosis and campylobacteriosis. 
1.1. Parameters for treatment application 
The Applicant includes the following information in relation to the parameters for treatment 
application in the dossier:  
 Where in processing line: PAA can be used at three steps in poultry processing: (1) on warm 
eviscerated carcasses or parts (pre-chill); (2) on carcasses in chiller baths (chill); (3) on 
chilled carcasses or parts (post-chill). PAA is typically added to water in equipment already 
present in the processing line. 
 Application: PAA can be applied as spray washing or dipping depending on the step in the 
processing line: (1) the pre-chill treatment is to be carried out by either spray washing or 
short-duration dip treatment; (2) the chill treatment is to be carried out in chiller baths, either 
during an entire chill or in one or more stages of multi-stage chiller baths; (3) the post-chill 
treatment is to be carried out in short-duration dip treatment.  
 Concentration: The concentrated stock PAA solution is diluted with potable water, to reach a 
concentration of the active ingredient, the peroxyacetic acid, not to exceed 2 000 ppm in the 
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short term baths, and up to 230 ppm in the long duration chiller baths. The concentration in 
spray washes is typically 400-700 ppm. Minimum concentration levels are not regulated in the 
US. Suppliers of PAA report that it can be effective at 25-30 ppm. The concentration a poultry 
production facility applies will be a function of its performance objective and integrated into 
its HACCP plan, layout, and operating environment. The primary active ingredient is the 
peroxyacetic acid. The ratios of acetic acid and hydrogen peroxide to PAA vary somewhat in 
the products provided by different manufacturers. 
 Conditions of use: Deliberately elevated temperatures are not intended (the maximum 
temperature is ambient temperature). The pH of the diluted PAA solution is not to be adjusted 
and varies by the concentration and the water hardness. The pH of a 600 ppm solution is 
approximately 2.5. 
 Exposure time:  
- For the short term baths a maximum duration is specified (3 minutes), but the 
minimum duration has not been specified.  
- The duration of exposure during chilling can be 1-2 h at lower concentrations 
(typically in the U.S., around 90 ppm). PAA may also be used for less than the entire 
chill time (e.g. in one segment of a multiple-section chill tank system). 
- For the spray washing treatment (pre chill), the exposure times are short, typically less 
than 10 seconds being sprayed in a commercial inside-outside bird washer, with a 
wetted time ranging between 30 seconds to a few minutes before entering a 
subsequent processing step. 
 Volume to apply: Spray pressures and volumes are specific to the washers utilized by a 
processor. For typical commercially available washers, during the spray process the poultry 
carcass may receive 680-950 ml of water mostly delivered at about 900 kPa. The washing 
process often has two parts, with a final rinse pressure at about 300 kPa. About 1/8th of the 
water is used in the final rinse. Washing time is about 6-9 seconds per carcass. The PAA 
solution may also remain active during the drip time. 
 Subsequent removal conditions: It is not intended to subsequently remove the PAA solution 
from the poultry carcasses or poultry meat. The presence of PAA on the carcasses may 
provide some protection against recontamination during processing.  PAA is highly reactive 
and, when used in the presence of organic compounds, should dissociate very rapidly and lose 
antimicrobial properties.  
 Information has not been provided on the impact of washing and/or immersion steps after the 
application of the PAA, e.g. immersion cooling after the spraying of warm carcasses. 
 Recycling: PAA breaks down to acetic acid and water and is not recycled. As noted in the 
dossier, overflow from post-chill high PAA concentration tanks may run into the lower 
concentration chiller tanks in some facilities.  
1.2. Previous EFSA assessment in relation to PAA 
EFSA has assessed the toxicological risks to public health from possible reaction products of four 
substances when applied on poultry carcasses, among which were peroxyacids (EFSA, 2005). Based 
on the available data and taking into account that processing of poultry carcasses (washing, cooking) 
would take place before consumption, EFSA concluded that treatment with peroxyacid solutions, 
under the described conditions of use, would not be of toxicological safety concern although efficacy 
may also be reduced. It was noted that spraying of poultry carcasses with antimicrobials, by 
comparison to dipping and immersion treatments, will reduce the exposure to residues and by-products 
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that might arise. It was stressed that the use of antimicrobial solutions should not replace the need for 
good hygienic practices during processing of poultry carcasses, particularly during handling. The need 
to replace regularly the water of chiller baths was also stressed.  
Assessment of the efficacy of peroxyacids as an antimicrobial substance applied to poultry carcasses 
was also carried out by EFSA in 2005 (EFSA, 2005). Particularly, EFSA was asked to assess the 
efficacy of the peroxyacids on the growth and/or prevalence of some microorganisms and pathogens 
on poultry carcasses. The information provided was not sufficient to allow assessment of the efficacy 
of peroxyacids, for various reasons. In short, the protocols used were not always fully explained, and 
the processing conditions did not reflect the conditions and practices in Europe. In the trial on 
commercial processing lines, Salmonella was the only pathogen considered (not Campylobacter spp.). 
The two adequately described experiments were on a laboratory scale and were not sufficient to 
demonstrate the efficacy of peroxyacids under commercial conditions. 
In 2008 EFSA assessed the possible effect of four antimicrobial treatment substances, including 
peroxyacids, on the emergence of antimicrobial resistance, when such substances were applied for 
poultry carcass decontamination (EFSA, 2008). The conclusion was that despite a long history of use, 
there were no published data that the application of peroxyacids to remove microbial contamination of 
poultry carcasses at the proposed conditions of use has led to either the occurrence of acquired reduced 
susceptibility to peroxyacids, or to development of resistance to therapeutic antimicrobials.  
1.3. Approved uses of PAA 
In the EU, use of PAA as a sanitizer and disinfectant is permitted under Directive 98/8/EC (updated 
and replaced by Regulation (EU) No 528/2012)
5
 and Regulation No 1451/2007
6
. The uses for PAA 
solutions include: human hygiene biocidal products; private area and public health area disinfectants; 
veterinary hygiene biocidal products; food and feed area disinfectants, drinking water disinfectants; in-
can preservatives (non-food); preservatives used in liquid-cooling and processing systems; and 
slimicides. In Europe, no post-marketing surveillance data are collected / available. 
As specified in the dossier, in the USA, peroxyacids have been widely used as sanitizers and 
disinfectants, including: agricultural premises and equipment (e.g. poultry barns and cages between 
flocks); food handling premises; commercial, institutional, and industrial premises; residential and 
public access premises; medical premises and equipment. In addition, peroxyacids are permitted for 
use at various stages in the processing of red meat and poultry products. 
1.4. Aim of this assessment 
The aim of the present Scientific Opinion is to assess the safety and efficacy of PAA solution intended 
to be used by food business operators during processing for the reduction of pathogens on poultry 
carcasses and poultry meat, considering (1) the toxicological safety of the substance, (2) the efficacy, 
i.e. does the use of the substance significantly reduce the level of contamination of pathogens on 
poultry carcasses and poultry meat?, (3) the potential emergence of reduced susceptibility to biocides 
and / or resistance to therapeutic antimicrobials linked to the use of the substance, and (4) the risk 
related to the release of the processing plant effluents, linked to the use of the substance, into the 
environment. Each of these assessments is described. 
                                                     
5  Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal 
products on the market.  OJ  L 123, 24.4.1998, p. 1-63. 
6 Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme 
referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of 
biocidal products on the market. OJ L 325, 11.12.2007, p. 3-65. 
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2. The toxicological safety of the substance to humans 
2.1. Evaluation 
2.1.1. Technical data 
2.1.1.1. Identity of the substances and specifications 
As specified in Table 1 the composition by weight % of the stock solution may for each of the 
different components except water vary between: acetic acid 35-45, peroxyacetic acid 12-20, hydrogen 
peroxide 6-10, octanoic acid 0-3.2, peroxyoctanoic acid 0-1.4 and HEDP 0.1-1.0. 
Acetic acid 
Synonyms: ethanoic acid 
CAS Registry number: 64-19-7 
EC number: 200-580-7 
Chemical formula: C2H4O2 
Molecular weight: 60.05 
Acetic acid is authorized as a food additive E 260 with no intake limit (Commission regulation N
o
 
1129/2011
7
).  
Peroxyacetic acid 
Synonyms: Peracetic acid, PAA, Ethaneperoxoic acid 
CAS Registry number: 79-21-0 
Chemical formula: C2H4O3 
Molecular weight: 76.05 
Hydrogen peroxide 
Synonyms: dihydrogen dioxide 
CAS Registry number: 7722-84-1 
EC number: 231-765-0 
Chemical formula: H2O2 
Molecular weight: 34.01 
Octanoic acid 
Synonyms: Caprylic acid 
CAS Registry number: 124-07-2 
                                                     
7  Commission Regulation (EU) No 1129/2011 amending Annex II to Regulation (EC) No 1333/2008 of the European 
Parliament and of the Council by establishing a Union list of food additives. OJ 12.11.2011, L 295/1 
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EC number: 204-677-5 
Chemical formula: C8H16O2 
Molecular weight: 144.21 
Peroxyoctanoic acid 
Synonyms: Peroctanoic acid, peroxycaprylic acid, percaprylic acid 
CAS Registry number: 33734-57-5 
Chemical formula: C8H16O3 
Molecular weight: 160.21 
Structural formula:           
1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) 
Synonyms: ehdp, HEDP, HEDPA, ETIDRONIC ACID 
CAS Registry number: 2809-21-4 
EC number: 220-552-8 
Chemical formula: C2H8O7P2 
Molecular weight: 206.03 
Structural formula:           
No information is given on the purities of the different components in the commercial stock solutions 
for which authorisation is applied. Quality specifications for HEDP as a food additive have been 
published by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 2004). 
The PAA stock solution can be diluted on-site with potable tap water to the desired concentration of 
peroxyacetic acid for use as decontaminating treatment for raw poultry carcasses or poultry meat. 
When the concentrated stock PAA are diluted to the levels used for the decontamination of poultry 
carcasses and meat, the solutions are not considered to be a safety hazard. 
The stock solutions described in the application are produced from acetic acid, hydrogen peroxide, 
octanoic acid and HEDP. While acetic acid and hydrogen peroxide are known to have antimicrobial 
effects, their effects within these solutions are minimal. Acetic acid reacts with hydrogen peroxide to 
generate peroxyacetic acid with which it is in equilibrium. Therefore the amount and presence of 
acetic acid and hydrogen peroxide is critical for the concentration of the peroxyacetic acid and 
therefore the antimicrobial effect. Octanoic acid functions as a surfactant, wetting hydrophobic 
surfaces, particularly on meat. The presence of peroxyoctanoic acid in the solution is a consequence of 
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the reaction of octanoic acid with hydrogen peroxide. HEDP has no antimicrobial effects, it functions 
as a stabilizer in these solutions by preventing metal ions from catalyzing the breakdown of 
peroxyacetic acid and hydrogen peroxide (JECFA, 2005, 2006).  
From the information on the stock solution and the work solution provided by the Applicant the 
amount ranges of the different components are shown in Table 2. 
Table 2:  Ranges for the different components depending on the formulation and type of solution.  
Component Stock solution (% w/w) Work solution (after dilution) (ppm, mg/L) 
Peroxyacetic acid 12-20 230-2000 
Acetic acid 35-45 518-6 767 
Hydrogen peroxide 6-10 69-1 533 
Octanoic acid 0-3.2 0-533 
Peroxyoctanoic acid 0-1.4 0-233 
HEDP 0.1-1.0 1.2-133 
 
According to the Applicant, the levels of total peroxyacids can be determined by an iodine-sodium 
thiosulfate titration method for which commercial kits are available. Other analytical techniques 
for PAA in dilute solutions also exist (ECETOC, 2001; PAR/Cefic). For the quantification of 
HEDP levels in solutions, a titration technique is provided by JECFA (JECFA, 2004). Ion-
exchange HPLC based methods for the quantification of HEDP in water samples are described in 
the literature (Ma et al., 2007; Nowack, 1997). The Applicant did not supply details of any 
technique for the determination of HEDP in food matrices, including poultry meat and no 
information could be found in the literature. 
2.1.2. Consumer exposure assessment 
JECFA estimated the intake of each peroxyacid solution component on the basis of the residual 
amounts anticipated to be present on treated food (meat and vegetables) at the time of consumption 
JECFA (JECFA, 2005, 2006). Due to the instability of hydrogen peroxide, peroxyacetic acid, or 
peroxyoctanoic acid, no residues were anticipated to be present on foods that have been treated with 
these solutions. In contrast, residues of acetic and octanoic acids were expected to remain on treated 
foods that are not washed or further processed after treatment. The highly conservative estimate of the 
exposure to octanoic acid resulting from the use of the antimicrobial solutions was 1.9 mg/day and the 
mean intake of octanoic acid from foods consumed as part of the diet in the USA was estimated to be 
approximately 200 mg/day. Intake of acetic acid was not determined; its use as vinegar in and on 
foods would result in a greater exposure than that from the use of peroxyacid antimicrobial solutions. 
HEDP was expected to remain on treated foods not further washed, processed, or cooked. The highest 
estimate of intake of HEDP was 3.6 g/kg bw per day for the upper-bound estimate using a model for 
vegetables with a high surface area. The value was obtained from JECFA using national estimates of 
intake from the Czech Republic (2.2 g/kg bw per day), the USA (2.2 to 4.7 g/kg bw per day), and 
the United Kingdom (1.8 to 3.3 g/kg bw per day). 
In Europe, acetic acid is authorized as a food additive as quantum satis and with an acceptable daily 
intake (ADI) not specified (SCF 1986), In the USA octanoic acid is on the FDA Generally Recognized 
As Safe (GRAS) list as multipurpose ingredients in food, with a maximum use levels under Good 
Manufacturing Practice ranging from 10 mg/kg for various foods, up to 160 mg/kg in snack foods
8
. 
The GRAS status recognition was issued through experience based on common use in food and 
considering that the substance was used in food prior to January 1, 1958.  
EFSA (2005) on the basis of the draft EU concise food consumption database (EFSA, 2005), which at 
that time included France, Sweden and Italy, found that the average daily consumption of meat and 
                                                     
8  21CFR184.1025 (last update April 2013): 
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1025 
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meat products was estimated to be between 120 and 151 g/day for adults. Assuming that the 
concentration of the substances in the edible part of meat was identical to the concentration in the 
carcass the exposure of a 60 kg individual to peroxyacetic acid and hydrogen peroxide was estimated 
to be 0.63 μg/kg bw/day at the mean and 1.08 and 1.46 μg/kg bw/day at the 95th 
 
and 99
th
 
 
percentile of 
meat consumption, respectively. The exposure of a 60 kg individual to HEDP was 0.43 μg/kg bw/day 
at the mean and 0.74 and 0.99 μg/kg bw/day at the 95th and 99th percentile of meat consumption, 
respectively (EFSA, 2005). 
In the JECFA scenario, the inclusion of vegetables with a great surface to volume ratio in addition to 
meat for the estimation of exposure explains the higher value (3.6 μg/kg bw/day) as compared to the 
EFSA estimation (0.74 μg/kg bw/day) in which only meat and meat products are considered.  
When using the most recent food consumption figures and body weight at the individual level 
available in the EFSA Comprehensive European Food Consumption Database (EFSA, 2011) which 
comprises 28 different dietary surveys carried out in 17 different European countries, the mean and 
high (95
th
 percentile) poultry consumption for adults (≥ 18 years to < 65 years old) in Europe ranges 
from 0.1 to 0.6 g/kg bw/day and 0.5 to 2.2 g/kg bw/day, respectively. The mean and high (95
th
 
percentile) poultry consumption for toddlers (≥ 12 months to < 36 months old) in Europe ranges from 
0.2 to 2.5 g/kg bw/day, and from 1.1 to 7.8 g/kg bw/day, respectively.  
The highest concentration of up to 2 000 mg/kg (short term bath i.e. <3 min) of peroxyacetic acid (see 
Table 2) which is about 10 fold higher than the value used in previous exposure assessments (EFSA, 
2005, JECFA 2005, 2006) leads to a residue level of 1883 µg HEDP/kg poultry
9
. The residue of 
HEDP on chicken carcasses that resulted from the low-concentration short-term treatment were only 
estimated by correction of the residue observed after a short-time low / concentration treatment for the 
difference in HEDP concentrations between the low- and high-concentration treatment. It was not 
investigated whether treatment time would greatly affect the residue level. Nevertheless, if it is 
assumed that HEDP is not absorbed by the carcass, this is a reasonable approach. If, however, HEDP 
is absorbed by the carcass, then this assumption is conservative, since the low-concentration treatment 
last longer than the high-concentration treatment and has therefore a higher potential for 
concentration-build-up in the poultry meat. 
Assuming that there is no loss of HEDP during the processing, the maximum residue level of 1 883 µg 
HEDP/kg poultry has been used in the exposure calculations. On this basis, for adults the mean and 
high (95
th
 percentile) poultry exposure to HEDP ranged from 0.18 to 1.16 µg/kg bw/day and 0.90 to 
4.18 µg/kg bw/day, respectively. For toddlers the mean and high (95
th
 percentile) poultry exposure to 
HEDP ranged from 0.34 to 4.76 µg/kg bw/day and 2.07 to 14.62 µg/kg bw/day, respectively.  
2.1.3. Toxicological assessment 
FDA, EFSA (section 1.2) and JECFA have already evaluated products containing peroxyacids. The 
EFSA guidance for the evaluation of the safety and efficacy of substances for the removal of microbial 
surface contamination of foods of animal origin intended for human consumption (EFSA, 2010) does 
not stipulate a fixed set of toxicological studies. 
The stock solutions evaluated in this opinion (see Table 2) are, with regard to their components, 
qualitatively identical to the solutions formerly evaluated and accepted as potential antimicrobial 
washing products for carcasses (EFSA, 2005). Formulations assessed by EFSA in 2005 contained 
peroxyacetic acid (<15 %), peroxyoctanoic acid (<2 %), hydrogen peroxide <10 %) and HEDP at 
levels lower than 1 %. The solutions were intended to be used at a maximum concentration of total 
peroxyacetic acid, of 220 mg/L, a maximum concentration of hydrogen peroxide of 110 mg/L, and a 
                                                     
9  Quotation from the memorandum dated April 3, 2009 referring to FCN00880 (FDA, 2009): “The maximum HEDP 
concentration in solutions applied to poultry carcasses in the current FCN is 10.46 times higher than the concentration of 
solutions applied to poultry in testing used to support FAP 1A4728 (136 ppm vs. 13 ppm). Therefore, the quantity of 
HEDP from this use would be 180 ppb x 10.46, or 1883 μg/kg poultry.” 
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maximum concentration of HEDP of 13 mg/L (EFSA, 2005). JECFA (2005, 2006) considered the 
safety of antimicrobial solutions for which the concentrations of total peroxyacid(s) before use ranged 
from 80 to 200 mg/kg solution. These solutions, as per the current evaluation, were prepared from 
acetic acid, octanoic acid (singly or in combination), hydrogen peroxide, and HEDP as stabilizer 
(EFSA Panel on Biological Hazards (BIOHAZ), 2011b; JECFA, 2005, 2006). 
In general, due to the instability of the peroxy-compounds, after dilution and application to the target 
(a carcass) mainly acetic acid, and octanoic acid will remain together with HEDP (Azanza, 2004). 
JECFA also indicates in their conclusion in 2005 that due to the reactivity of the peroxy compounds, 
only octanoic acid, acetic acid and HEDP will remain in food that are treated with the antimicrobial 
solution and that are not further washed, processed or cooked. 
The EFSA assessment from 2005 quotes experiments made to establish residues of peroxyacetic and 
peroxyoctanoic acids and HEDP (EFSA 2005). In those experiments the residues of peroxyacids and 
hydrogen peroxide in chicken carcasses after 2, 5 and 10 min of  spraying peroxyacids (200 mg/L) and 
immersing them for 60 min at less than 4°C were below the detection limit of 1 mg/L. Because of the 
low levels of peroxy compounds observed and the chemical instability/reactivity these substances are 
not likely to remain in the poultry carcasses and therefore there is no need to perform a safety 
assessment for these substances. Concerning HEDP, six chicken carcasses were treated with two 
different solutions. Solution 1 contained 200 mg/L of peroxyacids (as peroxyacetic acid) and 10 mg/L 
of HEDP and solution 2 contained 30 mg/L of peroxyacids and 1.5 mg/L of HEDP. All chicken 
carcasses were sprayed 15 s with solution 1 at ambient temperature. Three of the chicken carcasses 
were then immersed for 60 min in a bath at 3 ºC with solution 1 and the other three chicken carcasses 
were immersed for 60 min in a bath at 2 ºC with solution 2. Chicken carcasses treated with solution 1 
in the bath gave a residual amount of 120-170 μg HEDP per kg carcass. In the case of solution 2 in the 
bath, the residual amount was 40-50 μg HEDP per kg carcass (close to the LOD). 
From the above information it can be concluded that only acetic acid, octanoic acid and HEDP will 
remain in the carcasses after treatment without further washing or processing. 
A number of amino acids and amino acid-derived compounds such as peptides and proteins may be 
oxidized by the peroxyacids present in the PAA solution (EFSA, 2005). Cystine can, for example, be 
oxidised to cysteic acid and methionine to methionine sulphoxide or methionine sulphone (Slump and 
Schreuder, 1973; Strange, 1984). Although there are several possibilities for the oxidation of amino 
acids, it was concluded that “no significant levels of amino acids by-products will be produced after 
treatment with peroxyacids since free amino acids levels in poultry meat, just before ageing, are very 
low” (EFSA, 2008). The application of peroxyacids solution could also cause oxidation of lipids from 
fatty acids with one or more double bonds (EFSA, 2008; Rhee et al., 1989). In this respect, in 2005 
EFSA concluded that no significant differences in the TBARS (thiobarbituric acid reactive substances) 
values or the fatty acids profiles were observed when comparing treated samples with either raw or 
cooked samples (EFSA, 2005). 
Both risk assessments performed by JECFA (2005, 2006) and EFSA (2005) conclude that the use of 
the evaluated solutions are of no health concern. 
According to the risk assessment of JECFA (2005, 2006) several studies (human, rat, rabbits, dogs and 
monkeys) on the disposition of HEDP after oral administration have been performed. Collectively, the 
data indicated that absorption of HEDP from the gastrointestinal tract is very limited and that its 
metabolism is negligible. Some accumulation was seen in the bones, with a half-life in rats of about12 
days (JECFA, 2005, 2006). 
HEDP did not induce mutations in a bacterial gene mutation assay (Ames test) nor in an in vitro 
mammalian cell gene mutation test in L5178Y TK+/- mouse lymphoma cells (EC 2000, JECFA 2006). 
The unpublished study reports were, however, not available for re-evaluation. 
Safety and efficacy of peroxyacids for decontamination of poultry carcasses  
 
 
16 EFSA Journal 2014;12(3):3599 
Data on toxicity of HEDP have been provided by the Applicant from several studies referred to in the 
assessments by JECFA (2005, 2006), EFSA (2005) and FDA (2009): 
 Two 90-day studies with rats: NOAEL 500 mg/kg bw/day  
 One 90- day study with dogs: NOAEL 250 mg/kg bw/day  
 One study with two generations of rats: no teratogenic effects at 50 or 250 mg/kg bw/day with 
a NOAEL at 50 mg/kg bw/day (embryotoxicity found at 250 mg/kg bw/day)  
 One reproductive study with rabbits: NOAEL 50 mg/kg bw/day  
 One study of the treatment of human Paget disease (bone growth disorder): the prescribed 
treatment is up to 5 mg/kg bw/day for up to six month periods; this may be followed by 
additional treatments after rest period. 
 One 1-2 year subcutaneous (SC) study in dogs: NOAEL: 5 mg/kg bw/day (actual dose 0.01 
mg/kg bw/day via SC injection; the NOAEL mentioned here is the oral equivalent of the SC 
dose after adjustment for gut absorption. 
From the studies mentioned above, the Panel considered the two-year study in dogs inappropriate to  
be used for the safety assessment of HEDP, since this study included relatively small numbers of 
animals, it only addressed skeletal effects and it used a parenteral route of exposure, which creates 
additional uncertainty in the extrapolation. A chronic feeding study in rats provided a NOAEL of 105 
mg/kg bw/day, but this study was not available for evaluation. Lower NOAELs have been reported in 
reproductive toxicity studies in rats and rabbits (50 mg/kg bw/day). None of these studies was 
available for evaluation but based on FDA data, from these studies a NOAEL of 50 mg/kg bw/day 
emerges, also taking into account that in the study in rabbits a LOAEL of 100 mg/kg bw/day was 
reported. Assuming that the NOAEL of 50 mg/kg/bw/day was found in adequate studies, this NOAEL 
will be used for the safety assessment of HEDP. 
For adults mean and high (95
th
 percentile) poultry exposure estimates to HEDP from the use of the 
application as outlined in this opinion are up to 1.16 µg/kg/bw/day and 4.18 µg/kg/bw/day, 
respectively. Margin of Safety (MoS) for HEPD was calculated by dividing the NOAEL value of 
50 000 µg/kg bw/day by the mean or high exposure estimates resulting in MoSs of 43 103 and 11 961, 
respectively.  
For toddlers mean and high (95
th
 percentile) poultry exposure estimates to HEDP are up to 4.76 
µg/kg/bw/day and 14.62 µg/kg/bw/day, respectively. MoSs for HEDP were calculated for the mean 
and the high exposure as described above resulting in MoSs of 10 504 and 3 420 respectively.  
Based on the assumption that the data available provide an adequate NOAEL for HEDP, these MoS 
values, calculated for adults and toddlers do not indicate a safety concern. The Panel notes, however, 
that the respective studies from which NOAEL was derived, were not available to assess their 
reliability. 
2.2. Conclusions 
Accepting the previous EFSA exposure scenarios (EFSA, 2005), which included all uses described by 
the present application, except for the short term bath (< 3 minutes) using a ten times higher 
concentration than previously evaluated by the JECFA (2005, 2006) and EFSA (2005), no toxicity 
concerns were identified with regard to residues of peroxyacids due to the described high instability, 
including the use of the short term high concentration bath. No concerns are indicated with respect to 
residues of acetic acid and octanoic acid, respectively, again including the short term use of a high 
concentration bath.  
With regard to the product stabilizer HEDP no safety concern was identified with regard to the high 
concentration bath since for HEDP MoSs ranging from 3 420 to 43 103 can be calculated against a 
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NOAEL of 50 mg/kg bw/day obtained in rat and rabbit reproductive toxicity studies. The Panel noted 
that since the studies from which these NOAELs were derived were not available to be evaluated there 
is some uncertainty as to the validity of the NOAEL used. In addition, this conclusion is only 
applicable for working solutions of PAA containing up to 130 mg HEDP/L in combination with 
immersion times of 3 minutes. When longer contact times are applied, the HEDP concentrations 
should be reduced accordingly. 
Regarding the question of the safety of possible reaction products of hydrogen peroxide and 
peroxyacids with lipids and proteins/amino acids of the poultry carcasses, the low amino acid content 
in the carcass surface used as argument for the former EFSA (2005) conclusion that no risk was 
expected, is still valid, including the short term treatment at higher peroxide concentrations. 
With regard to lipid peroxidation, no by-products were identified in producer experiments referred to 
in the previous risk assessment, when using immersion for 60 minutes in 200 mg/L total peroxyacetic 
acid. On this basis short term high concentration bath scenario included in the present application is 
not expected to cause measurable lipid peroxidation. 
2.3. Recommendations 
To control residues of HEDP on poultry carcasses, monitoring of the concentration of HEDP in the 
working PAA solution should be considered in the HACCP plans.  
A method for the determination of HEDP residues in poultry carcasses, poultry meat and poultry meat 
products should be developed and validated, to further inform the risk assessment. 
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3. The efficacy, i.e. does the use of the substance significantly reduce the level of 
contamination of pathogens on poultry carcasses and poultry meat 
3.1. Introduction 
According to the EFSA guidance document (EFSA Panel on Biological Hazards (BIOHAZ), 2010), 
the use of substance(s) as decontaminating treatments will be regarded efficacious when any reduction 
of the prevalence and/or numbers of pathogenic target microorganisms is statistically significant as 
compared to the control (e.g. water) and, at the same time, this reduction has a positive impact on 
reduction of human illness cases (EFSA Panel on Biological Hazards (BIOHAZ), 2010).  
A risk assessment study on Campylobacter on broiler carcasses pre-chill (EFSA Panel on Biological 
Hazards (BIOHAZ), 2011a) has shown that even 0.5 log unit microbial reductions may reduce 
consumer risks to a significant extent. In addition, there is a linear correlation between reductions in 
prevalence and reductions of consumer risks. Efficacy depends on a range of factors such as 
concentration of the decontaminating agent, contact time, temperature, mode of application, the 
microbial load of the surface, and other conditions of application. 
3.2. Selection of studies for evaluation 
As indicated, use of PAA solutions, containing < 2 000 ppm or < 230 ppm of peroxyacetic acid, the 
active ingredient, was petitioned for approval as a decontaminant treatment in raw poultry carcasses 
and poultry meat. The process and results of the evaluation of the studies included in the dossier for 
the efficacy of PAA as a decontamination agent for raw poultry carcasses and poultry meat are 
evaluated in this section. 
3.2.1. Criteria used for inclusion or exclusion of submitted studies 
The following criteria were used in the selection of studies to be used in the evaluation of 
decontamination efficacy by PAA:  
 The studies considered were only those with criteria following within the conditions used as 
provided by the Applicant and described in section 1.1. 
- Treatment group 1: studies on warm carcasses with spray treatment: 
 Product treated: carcasses pre-chill; 
 Application: spray washing (in a commercial inside-outside bird washer); 
 PAA concentration: 400-700 ppm; 
 Maximum temperature: ambient; 
 Maximum duration of treatment: typically less than 10 seconds, with a wetted time 
ranging between 30 seconds to a few minutes before entering a subsequent 
processing step. 
- Treatment group 2: studies on warm carcasses or parts with dip treatment: 
 Product treated: carcasses pre-chill; 
 Application: short-duration dip treatment; 
 Maximum temperature: ambient; 
 Maximum PAA concentration: 2 000 ppm; 
 Maximum duration of treatment: 3 minutes. 
- Treatment group 3: studies on effects in chiller baths: 
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 Product treated: carcasses pre-chill; 
 Application: in chiller baths, either during an entire chill or in one or more stages 
of multi-stage chiller baths; 
 Maximum temperature: temperatures currently used in chilling baths; 
 Maximum PAA concentration: 230 ppm; 
 Maximum duration of treatment: 1-2 h at lower concentrations (in the US this is 
typically around 90 ppm). PAA may also be used for less than the entire chill time 
(e.g. in one segment of a multiple-section chill tank system). 
- Treatment group 4: studies on chilled carcasses or parts with dip treatment: 
 Product treated: carcasses or parts post-chill; 
 Application: short-duration dip treatment; 
 Maximum temperature: ambient; 
 Maximum PAA concentration: 2 000 ppm; 
 Maximum duration of treatment: 3 minutes. 
 The studies selected for evaluation should involve application on poultry carcasses, poultry 
skin, or skin-on poultry parts.  
 The studies on visibly contaminated poultry carcasses and poultry meat were excluded from 
the assessment. This is because decontamination treatments must not affect the food business 
operator‟s duty to comply with the requirements of EU legislation on food hygiene, as laid 
down in Regulation (EC) No 853/2004 Annex III, Section I, Chapter IV, point 10
10
 and should 
in no way be considered as a substitution for good hygienic slaughtering practices and 
operating procedures or as an alternative to comply with the requirements of those 
Regulations. The Annex of Reg. 101/2013, concerning the use of lactic acid to reduce 
microbiological surface contamination on bovine carcasses, stipulates that “lactic acid 
solutions must not be applied to carcasses with visible faecal contamination”.  
 The evaluation of the efficacy will focus on PAA treated samples versus water treated 
samples, or versus untreated controls. In the absence of a proper water treated control, data 
from solutions with a low chlorine concentration (around 30 ppm) as control were also used as 
these would lead to a conservative estimate of the overall efficacy. 
 The targets applied for by the Applicant are poultry-borne organisms regarded as important 
human pathogens. The evaluation of the efficacy will focus on Campylobacter spp., 
Salmonella spp. and Escherichia coli, including strains pathogenic to humans. This is based 
on the most relevant biological hazards that were identified in the context of meat inspection 
of poultry, i.e. thermophilic Campylobacter spp., Salmonella spp. and ESBL/AmpC gene-
carrying E. coli (EFSA Panel on Biological Hazards (BIOHAZ), 2012a). The evaluation will 
also take into account information on relevant indicator organisms, i.e. Escherichia coli, 
coliforms and Enterobacteriaceae. Reduction of spoilage organisms is regarded as a secondary 
objective since it is not expected to have any impact on the target pathogens, which do not 
grow on chilled poultry meat. 
 The studies in which inoculation of the microorganisms was done after the PAA treatment 
were excluded from the assessment as these were not considered to represent practical 
applications. 
                                                     
10  Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific 
hygiene rules for on the hygiene of foodstuffs, Official Journal of the European Union 30.4.2004, L 139/55.  
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3.2.2. Determination of the strength of evidence of selected for evaluation of studies 
The body of evidence selected (see below) from the studies submitted in the dossier was evaluated, 
taking into account whether the studies were done in the laboratory, under pilot plant conditions or in a 
slaughterhouse (industrial scale), and whether they used inoculated or naturally-contaminated poultry 
samples. Table 2 summarizes the weight given to the data from naturally-contaminated versus 
inoculated samples and industrial-scale versus pilot-scale versus laboratory-scale studies. These 
criteria have been used in three previous EFSA Opinions (EFSA Panel on Biological Hazards 
(BIOHAZ), 2011a, 2011b, 2012b) and were developed on the basis of the FAO/WHO report on 
Benefits and Risks of the Use of Chlorine-containing Disinfectants in Food Production and Food 
Processing (FAO/WHO, 2008). The results of this evaluation are shown in Tables 3 and 4. 
Table 3:  Relative strength of the contribution of study data to the general body of evidence, based 
on study type 
Study type Natural contamination Inoculated studies 
(a)
 
Industrial High Not applicable 
Pilot-scale 
(b)
 High 
(c)
/medium Medium 
(d)
 
Laboratory Medium 
(d)
 Low 
(e)
 
(a): Includes studies where the meat surface was inoculated with pathogens in pure culture prior to the decontamination 
treatment. 
(b): Experiments using industrial equipment in non-industrial settings. 
(c): If the pilot process is representative of the industrial process; otherwise, evidence makes a “medium” contribution to 
the body of evidence. 
(d): Data would not be sufficient to inform a quantitative microbial risk assessment or to allow definitive conclusions on 
risk reduction. 
(e) Data are indicative of a disinfectant effect that may be reproducible in practice, but individually do not allow definitive 
conclusions on risk reduction. 
3.3. Results of the selection of studies for evaluation 
 The application dossier included eight peer-reviewed published papers and one conference 
proceeding dealing with testing of PAA solution for decontamination (Table 4). All but one 
(the conference proceeding) were selected for consideration in evaluating the efficacy of PAA 
solution in poultry meat decontamination. The papers totalled ten studies, of which two were 
industrial, two pilot, and six laboratory level studies. One study was conducted on short-
duration dip treatment pre-chill (treatment group 2 in Table 4), four in chiller baths (treatment 
group 3 in Table 4), and five by short-duration dip treatment post-chill (treatment group 4 in 
Table 4). 
 Of the peer-reviewed studies that were included, three were of high strength of evidence, three 
of medium strength and five of low strength (Table 4).  
 The Applicant also included in the application dossier 15 reports with data of in-house studies 
in support of the application for approval of PAA solution for use in the decontamination of 
fresh poultry products (Table 4). All but four of these reports were considered in the 
evaluation of the efficacy of PAA solution against microbial contamination on fresh poultry; 
rejection was because either only total viable bacteria were tested, the duration of the 
treatment was outside the range of the application, the concentration used was above the 
treatment limit, or no warm carcasses were used. The 11 reports that were included totalled 15 
studies. 
 Twelve of the in-house studies were conducted on poultry carcasses (Table 4) with natural 
contamination, ten were of industrial scale, two of pilot scale, and three laboratory scale. 
Seven studies were conducted by spray-washing of carcasses or parts pre-chill (treatment 
group 1 in Table 4), two on short-duration dip treatment pre-chill (treatment group 2 in Table 
4), four in chiller baths (treatment group 3 in Table 4), and two by short-duration dip treatment 
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post-chill (treatment group 4 in Table 4). The PAA solution was not removed or rinsed in all 
studies.  
 Ten of the in-house studies were classified as of high strength of evidence, two of medium, 
and three of low strength (Table 4).  
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Table 4:  Studies submitted by the Applicant and the reasons for inclusion/exclusion from the assessment 
Paper 
number 
Type of 
paper/study (a) 
Reference Include in 
assessment  
Reason for 
exclusion 
Industrial/ 
pilot/lab 
Natural/ 
inoculated 
Microorganisms Product 
group 
Strength of 
evidence
h
 
Treatment group 1: studies on warm carcasses with spray treatment 
1 IHS (Abraham et al., 
2006) 
YES  Industrial Natural Salmonella (b), E. coli, 
coliforms
 
Broiler carcass High 
2 IHS (Abraham et al., 
2007) 
YES  Industrial Natural Salmonella (b), E. coli, 
coliforms
 
Poultry carcass High 
9 IHS (Dankert, 2011) YES  Industrial Natural Salmonella (b), E. coli Poultry carcass High 
13 IHS (FMC, 2009) YES  Industrial Natural Salmonella (b), E. coli, 
coliforms 
Poultry carcass High 
14 IHS (FSIS et al., 
2012) 
YES  Industrial Natural Salmonella (b), E. coli Broiler carcass High 
18 IHS (Rodrigues and 
Howarth, 2010) 
YES  Industrial Natural Salmonella (b), E. coli Broiler carcass High 
12 IHS (Ecolab, 2001) YES  Pilot Natural E. coli, coliforms
 
Poultry carcass Medium 
15 IHS (Hochmuth, 
2000) 
NO Not warm carcasses 
used 
     
Treatment group 2: studies on warm carcasses or parts with short-duration dip treatment 
3 IHS (Abraham et al., 
2010) 
YES  Industrial Natural Salmonella (b), E. coli, 
coliforms  
Broiler carcass High 
4 IHS (Abraham, et al., 
2011) 
YES  Industrial Natural Salmonella (b), E. coli, 
coliforms  
Broiler carcass High 
24 IHS (Verkaar, 2006) NO Only total viable 
bacteria included  
     
16 PR (Mehyar et al., 
2005) 
YES  Laboratory Inoculated Salmonella (e), 
C. jejuni, E. coli 
O157:H7 
Chicken wing 
parts 
Low 
Treatment group 3: studies on effects in chiller baths 
6 PR (Bauermeister et 
al., 2008b) 
YES  Industrial Natural Salmonella, 
Campylobacter
 
(b)
 
Broiler carcass High 
9 IHS (Dankert, 2011) YES  Industrial Natural Salmonella, E. coli  Broiler carcass 
and chicken 
parts 
(c)
 
High 
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Paper 
number 
Type of 
paper/study (a) 
Reference Include in 
assessment  
Reason for 
exclusion 
Industrial/ 
pilot/lab 
Natural/ 
inoculated 
Microorganisms Product 
group 
Strength of 
evidence
h
 
13 IHS (FMC, 2009) YES  Industrial Natural Salmonella (b), 
Campylobacter, E. coli, 
coliforms 
Poultry 
carcass. Study 
in a turkey 
processing 
plant 
High 
21 IHS (Thompson et al., 
2009) (c)
 
NO Concentration used 
exceeds limit of 
chilling baths (230 
ppm) 
     
23 PR (Vadhanasin et 
al., 2004) 
YES  Industrial Natural Salmonella
 
(b) Broiler carcass High 
5 PR (Bauermeister et 
al., 2008a) 
YES  Pilot Natural E. coli, coliforms  Broiler carcass High 
12 IHS (Ecolab, 2001) YES  Pilot Natural E. coli, coliforms
 
Poultry carcass Medium 
5 PR (Bauermeister et 
al., 2008a) 
YES  Laboratory Inoculated S. Typhimurium, 
C. jejuni
 
Broiler carcass Low 
15 IHS (Hochmuth, 
2000) 
YES  Laboratory Inoculated S. Typhimurium, E. coli 
O157:H7 
Chicken wings Low 
22 CP (c) (Trevanich et al., 
2003)
 
NO Not full details 
available 
     
Treatment group 4: studies on chilled carcasses or parts with short-duration dip treatment 
10 PR (Del Rio et al., 
2007a)
g
 
YES  Laboratory Natural Enterobacteriaceae, 
coliforms 
 
Chicken legs Medium 
17 PR (Nagel et al., 
2013) 
YES  Pilot Inoculated S. Typhimurium, 
C. jejuni 
Broiler carcass Medium 
7 PR (Chantarapanont 
et al., 2004)
g
 
YES  Laboratory Inoculated C. jejuni Chicken skin Low 
8 IHS (Dankert, 2010)
g
 YES  Laboratory Inoculated Salmonella, E. coli Chicken part 
and carcass 
Low 
11 PR (Del Rio et al., 
2007b)
g
 
YES  Laboratory Inoculated S. Enteritidis, E. coli 
 
Chicken legs Low 
16 PR (Mehyar et al., 
2005) 
YES  Laboratory Inoculated Salmonella (e), 
C. jejuni, E. coli 
O157:H7 
Chicken wing 
parts (f) 
Low 
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Paper 
number 
Type of 
paper/study (a) 
Reference Include in 
assessment  
Reason for 
exclusion 
Industrial/ 
pilot/lab 
Natural/ 
inoculated 
Microorganisms Product 
group 
Strength of 
evidence
h
 
19 IHS (Rodrigues and 
Howarth, 2011) 
NO Duration of the 
treatment was 5 
min 
     
20 IHS (Rodrigues et al., 
2011) 
YES  Laboratory Inoculated S. Typhimurium, 
C. jejuni 
Broiler carcass Low 
(a):  PR=peer reviewed paper;  IHS=in-house study. 
(b):  Prevalence study. 
(c):  Poster of FMC corporation presented at annual meeting of International Association for Food Protection. 
(d): Washed is given in paper (assumed is dipping). 
(e): Cocktail of two strains of Salmonella Typhimurium and one strain of S. Heidelberg. 
(f):  Obtained from retail. 
(g):  Studies classified by the Applicant under treatment group 2, but reclassified under group 4 because warm carcasses were not used. 
(h):  Strength of evidence assigned as presented in Table 2. 
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3.4. Statistical significance and statistical methods used 
In this section the statistical methods used in the studies included in the assessment are discussed. The 
statistical methods used for analysing experimental data were reported in varying levels of detail, and 
in many papers were not fully documented. Several papers applied appropriate methods, but for other 
papers the appropriateness cannot be fully evaluated or can be questioned.  
Papers 1 and 2 provided detailed descriptions of the statistical methods, including testing for normal 
distribution of count data. If data were not normally distributed, log-transformation does not appear to 
have been attempted but the non-parametric Mann-Whitney test has been applied. This test is 
appropriate for non-normally distributed data but less powerful than parametric tests on log-
transformed data. In papers 3 and 4 (by the same first author), log transformation of count data was 
reported before applying Analysis of Variance (ANOVA).  
Papers 5, 7, 9, 10, 11, 12 also used ANOVA on log-transformed data to evaluate differences between 
factors in the experiments. Paper 17 used generalised linear models. Duncan‟s multiple range test was 
used to accommodate for multiple comparisons in papers 10 and 11. These methods are considered 
adequate for the purpose of this Scientific Opinion, although testing for normal distributions or log-
transformations were not explicitly reported in papers 7 and 9. 
Papers 18 and 20 used t-tests assuming unequal variances, which may be appropriate. Details on data 
transformation were lacking, as well as results for tests of equal variance, so that the statistical 
methods cannot be fully evaluated.  
Handling zero counts has either not been reported by the authors, or follows difference conventions, 
replacing zeros by 1, 0.9 or 0.5 times the limit of quantification. The impact of these differences 
cannot be evaluated because the number of zero counts relative to the total number of counts has not 
been reported in any of the papers. 
In papers 1, 2 and 9, presence-absence data were appropriately evaluated by contingency tables and X
2
 
tests, or Fischer‟s exact test to account for low prevalences. Paper 6 reported only presence/absence 
data, which were analysed by ANOVA. This is surprising as ANOVA is typically used for count data. 
Statistical methods could not be evaluated for paper 16 (only use of SAS software is mentioned). No 
statistical analysis was reported in papers 8, 13, 14 and 23.  
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3.5. Evaluation of studies 
The studies in the papers evaluated encompassed a wide range of experimental designs and thus 
differed in relation to products, settings, method of application, PAA concentration applied, 
temperature of application, types of controls used, microorganisms studied and the microbial load of 
the surface, microbiological methods used, storage time after application, etc. All of these parameters 
impacted on the PAA decontaminating efficacy both within and between studies. Given this wide 
range of application conditions, the assessment did not attempt to identify the contribution of 
differences among factors, such as PAA concentration and application temperature on the bactericidal 
effect. 
In this section, a brief summary of the experimental set-up and main results and conclusions of each 
chapter are provided per treatment group. Then, the combined data for each treatment group are 
presented in forest plots, separately for enumeration and prevalence studies. For enumeration studies, 
decimal reduction values are presented with confidence intervals calculated by EFSA when the mean, 
standard deviation and sample size were known and /or raw data were available in the studies as 
provided by the Applicant and if variances between groups are equal as:  
Mean decimal reduction (MDR)  
Confidence intervals (CI) of MDR =  
Where: 
 µ = Mean bacterial counts of control (µbacterial counts, C) or treatment (µbacterial counts, T) group 
 SD = Standard deviation of mean bacterial counts of control (SDC) or treatment (SDT) group 
 n = Sample size control (nC) or treatment (nT) group 
For prevalence studies, the relative prevalence reduction (RPR) and confidence intervals (if the 
absolute number of positive samples in the controls were >5) were calculated as: 
Relative Prevalence Reduction (RPR)  
Confidence intervals (CI) of RPR  
Where: 
  = Positive samples in the control group 
  Positive samples in the treatment group 
 n = Sample size control (nC) or treatment (nT) group 
If absolute number of positive samples in treated group were <5 then CI were calculated by using the 
asymptotic method by Miettinen and Nurminen (robust approximation) (Miettinen and Nurminen, 
1985; Newcombe, 1998).  
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Where: 
  = C+/nC – T+/nT 
  = (C+/nC + T+/nT)/2 
  = (nC+nT)/( nC+nT -1) 
 z = 1.96 
 m = sample size of control group 
 n = sample size of treatment group 
Finally, summary tables of results in different treatment groups are presented with conclusions. In 
these summary tables, results are presented separately depending on the availability of confidence 
intervals. For enumeration studies, results are considered relevant if the CI did not include 0 or, if CI 
were not available, following expert judgement, if the decimal reduction value was more than 0.5 log-
units higher or lower than zero. For prevalence studies, CI were computed with the above formula if 
the absolute number of positive samples in the controls were >5, otherwise the trials were excluded 
from the summary graphs. The results were considered significant if the CI of the relative prevalence 
reduction did not include 0. 
3.5.1. Treatment group 1: studies on warm carcasses with spray treatment 
3.5.1.1. High strength of evidence studies on warm carcasses with spray treatment 
Paper 1 (Abraham et al., 2006) 
Set up: This is an online study where 25 ppm PAA was used in an online reprocessing (OLR) system, 
on 20 clean carcasses compared to 20 untreated clean carcasses. The OLR system is a spray cabinet set 
at a flow rate of 12 gallons per min. OLR sprays are typically 2-3 sec spray time followed by 30-60 
sec drip time. All carcasses were tested for coliforms and E. coli counts, and Salmonella prevalence. 
Results and conclusions: The E. coli and coliform counts were 0.72 and 0.59 log units lower on clean 
treated carcasses compared to untreated carcasses respectively. Salmonella was not detected on clean 
untreated carcasses and therefore Salmonella reduction could not be evaluated.  
Paper 2 (Abraham et al., 2007)  
Set up: In this study on-line reprocessing PAA treatments (from 50-180 ppm, 120-180 ppm, and 105 
ppm) were tested in three different commercial facilities. Sampling and testing of carcasses were 
performed after cleaning and inspection. Only samples from visibly clean carcasses were considered. 
Twenty samples from each category (treated and untreated) were sampled for E. coli, coliforms 
(quantitatively) and Salmonella (qualitatively) at five, three and four occasions respectively at the 
three plants.  
Results and conclusions: The E. coli reduction in treated versus untreated visually clean carcasses was 
1.2, 0 and 1.0 log units in the three plants. Coliforms in treated versus untreated visually clean 
carcasses were reduced by 1.3, 0.1 and 1.0 log units in the three plants. Salmonella samples were only 
obtained from plant 1 and 2. In plant 1 a 87 % relative prevalence reduction of Salmonella was found 
in visibly clean carcasses (proportion positive carcasses reduced from 23/100 to 3/100). In plant 2 a 
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40 % relative prevalence reduction (proportion positive carcasses reduced from 5/60 to 3/60) was 
found in visible clean carcasses. 
Paper 9 (Dankert, 2011) 
Setup: The study represented an industrial evaluation of pathogen reduction by spraying with 40-
95 ppm PAA (estimated average was about 73 ppm PAA) for 2-3 seconds and a total wetted time at 30 
to 45 seconds. Three groups of 60 naturally-contaminated but visibly clean carcasses were 
quantitatively analysed for E. coli and qualitatively for Salmonella before and after treatment. 
Results and conclusions: The study showed a reduction from 2.79 to 1.99 log units/g of E. coli. 
Salmonella prevalence was reduced from 50.5 % to 36.1 %.  
Paper 13 (FMC, 2009) 
Setup: This study (trial 2) represented an industrial investigation of the reduction of naturally 
contaminated carcasses by spray treatment in OLR Cabinet and Chiller – four different sites in two 
production lines (line 1: 90-105 ppm PAA; line 2: 135 ± 15 ppm PAA). For each treatment, samples 
for quantitative analysis for E. coli and coliforms and qualitative analysis for Salmonella were 
collected after evisceration (pre-treatment) and after the last washing cabinet (post-treatment). 20 
carcasses were investigated at each point. 
Results and conclusions: The results showed a log reduction of coliforms (line1/line2) of 1.33 and 
0.95 log units/g and for E. coli (line1/line2) of 1.34 and 0.76 log 10 units /g. At the first line Salmonella 
was not reduced by the treatment (75 % prevalence both pre- and post-treatment), whereas at the 
second line the relative prevalence reduction was 70 %; prevalence declined from 50 % to 15 %. 
Paper 14 (FSIS et al., 2012)  
Set up: Summary report from commercial facilities tests of the efficacy of on-line reprocessing (OLR) 
systems using antimicrobial sprays. Six of the 11 data sets included in the study used PAA. 
Concentrations of PAA and specific conditions in each plant were not provided, although all but one 
included a measurement of both clean and contaminated carcasses. A clean poultry carcass was 
inspected by Federal inspection personnel and did not require reprocessing. A dirty or contaminated 
poultry carcass was inspected and required reprocessing because of visible digestive tract 
contamination in the carcass cavity. Given current industry practice, most of the OLR treatments were 
most probably in the range of 150 to 200 ppm PAA.  
APC and E. coli abundance and Salmonella prevalence were measured in all plants  
Results and conclusions: 
Data generated from the in-plant trials demonstrated that the technologies used in the studies yielded 
definite improvements. 
 Both OLR and off-line reprocessing (OFLR) in-plant trials demonstrated an average log 
reduction for APC, E. coli and coliforms. Both OLR and OFLR demonstrated a percent 
positive reduction for Salmonella.  
 OLR sample size range: 823 – 1990.  
 OFLR sample size range: 205 – 210.  
 Although OFLR demonstrated a larger average log reduction for APC, E. coli and coliforms 
than OLR, the larger sample size for the OLR studies demonstrated the higher confidence with 
which OLR systems would achieve a definitive improvement for average log reduction.  
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 OLR had a better Salmonella-positive reduction then OFLR.  
The results showed a log reduction of E. coli (plant 1, 2, 3, 4, 5) of 1.24, 0.30, 0.01, 1.30 log units and 
as small increase (0.72 log units in plant 6). Relative prevalence reductions in plants 1, 2, 3 and 5 were 
68.0 % (decline from 68.8 % to 22 %), 60.9 % (decline from 23.0 % to 9.0 %), 19.2 % (decline from 
5.0 % to 4.0 %) and 0 % (prevalence remained 5.0 %). 
Paper 18 (Rodrigues and Howarth, 2010)  
Setup: Processing system in commercial facility. 100 ± 7 ppm PAA in spray cabinet. 2-5 seconds 
spray, 20 ± 5 seconds contact time at ambient temperatures. 109 or 110 carcasses sampled before and 
after spraying for both carcasses considered clean (passing inspection) and carcasses considered 
marginal (small amounts of visible ingesta or faecal material)  
Carcasses washed before sampling in an inside-outside bird washer with approximately 15 ppm PAA 
in the water (normal plant operation). Study conducted over 11 sampling days. Abundance of E. coli, 
APC and prevalence of Salmonella were measured. 
Results and conclusions: Low reduction by PAA treatment (< 1.5 log units) for E. coli; high (68 %) 
relative prevalence reduction of Salmonella (Salmonella prevalence reduced from 68.2 % to 21.8). 
3.5.1.2. Medium strength of evidence studies on warm carcasses with spray treatment 
Paper 12 (Ecolab, 2001) 
Set up: Pilot study with naturally-contaminated samples that were analysed by quantification of 
coliforms and E. coli. The objective of the study was to evaluate the effect of PAA in relation to 
reduction of spoilage or decay caused by bacteria, but in this context the occurrence of coliforms and 
E. coli were evaluated as indicators for pathogen contamination. The effect of spraying carcasses with 
200 ± 5 ppm PAA for 15 seconds at ambient temperature was evaluated by comparing to spraying 
with water. 
Results and conclusions: The results showed a reduction of contamination level of coliforms at 0.64 
log units after spraying with PAA compared to a reduction at 0.33 log units by spraying with water. 
For E. coli the reduction was 0.84 log units after spraying with PAA and 0.46 log units after spraying 
with water.  
3.5.1.3. Conclusions of studies on warm carcasses with spray treatment 
Forest plot of results obtained with spray treatment on warm carcasses are shown in Figures 1 and 2.
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Figure 1:  Forest plot of results obtained with spray treatment on warm carcasses (mean difference of bacterial counts; NS: not stated).  
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Figure 2:  Forest plot of results obtained with spray treatment on warm carcasses (relative prevalence reduction)
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Table 5 shows a summary of individual data sets from each study. In enumeration studies, there was a 
positive+ effect on E. coli (i.e. either a significant reduction of the log CFU or a mean decimal 
reduction > 0.5 log-units if CI were not provided) in 9/16 datasets; the mean decimal reduction ranged 
between 0.72 and 1.35 log-units. For coliforms, there was a positive effect in 6/9 studies, with mean 
decimal reduction ranging between 0.5 and 1.3 log-units. There was one dataset that indicated a 
significant increase of coliforms counts; two that indicated a significant increase of E. coli counts. All 
studies with indicator organisms were of high or medium strength of evidence. No enumeration data 
on pathogens were provided.  
Nine prevalence studies were included in the summary graphs (with the number of positive samples in 
the control group > 5) and were provided only for Salmonella. The Salmonella prevalence was 
significantly reduced in 6/9 datasets; the mean relative prevalence reduction was >50 % in 5/6 of those 
datasets. 3/9 studies showed a non-significant Salmonella prevalence reduction. All prevalence studies 
were of high strength of evidence and all showed reduction over untreated control samples. 
Table 5:  Summary of results of studies on warm carcasses with spray treatment  
Decimal reduction E. coli Coliforms Salmonella Campylobacter 
Enumeration studies, confidence interval provided 
Statistically significant reduction 5(0*) 4(1*) 0 0 
No significant effect 2* 1* 0 0 
Significant increase 1* 1* 0 0 
Enumeration studies, confidence interval not provided 
MDR > 0.5 log 4(0*) 2(0*) 0 0 
-0.5<MDR<0.5 log 3(0*) 1(0*) 0 0 
MDR < -0.5 log 1(0*) 0 0 0 
Prevalence studies 
Statistically significant reduction 0 0 6(0*) 0 
No effect 0 0 3(0*) 0 
* number of studies out of the total where water control was applied 
 
3.5.2. Treatment group 2: studies on warm carcasses or parts with dip treatment 
3.5.2.1. High strength of evidence studies on warm carcasses or parts with dip treatment 
Paper 3 (Abraham et al., 2010) 
Set up: Clean and dirty carcasses were treated on line in a commercial facility with 100, 200, 1000 and 
1 200 ppm PAA. Samples were taken after evisceration, washing, and inspection and after treatment 
with PAA. Each concentration was tested (submerged time 25 seconds) on a single day and flock. 
Twenty carcasses were sampled for each condition. All carcasses were treated and the purpose was to 
demonstrate that visible contaminated carcasses post treatment were microbiological equivalent to 
visibly clean birds before treatment. Only the efficacy on visibly clean carcasses was considered. 
Results and conclusions: The E. coli reduction in treated versus untreated (pre- versus post-treatment) 
visually clean carcasses ranged from 1.24 to > 2.5 log unit reduction. The reductions in coliforms 
ranged from 1.16 to above 2.94 log units. The log reduction increased with the PAA concentration 
used. The relative prevalence reduction in Salmonella was between 50-100 % in visibly clean 
carcasses. 
Paper 4 (Abraham, et al., 2011) 
Set up: Clean and dirty carcasses were treated on line in a commercial facility with 100, 500, 1000 and 
2 000 ppm PAA. Samples were taken after evisceration, washing, and inspection and after treatment 
with PAA. Each concentration was tested (submerged time 25 seconds) on a single day and flock. 
Twenty carcasses were sampled for each condition. All carcasses were treated and the purpose was to 
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demonstrate that visible contaminated carcasses post treatment are microbiological equivalent to 
visible clean birds before treatment. Only the efficacy on visible clean carcasses was considered. 
Results and conclusions: The E. coli reduction in treated versus untreated (pre- versus post-treatment) 
visually clean carcasses was from 1.94 to 2.91 log unit reduction (zero values were assigned a value 
equal to the detection limit. The log reduction increased with the PAA concentration used. The 
reduction in Salmonella prevalence was between 71-100 % in visible clean carcasses. In all cases 
where 1 000 and 2 000 ppm PAA were used the reduction in Salmonella prevalence was 100 %. 
3.5.2.2. Low strength of evidence studies on warm carcasses or parts with dip treatment 
Paper 16 (Mehyar et al., 2005)  
Setup: Chicken wing parts (drumettes) obtained from commercial processing plant after defeathering 
inoculated with strains of E. coli O157:H7, C. jejuni, and three strains of S. enterica by dipping into 
culture for 15 seconds then allowed to drain for 15 minutes. Treatment with 200 ppm PAA (formula 
containing octanoic acid) by dipping for 1 minute in treatment or water followed by 30 second drain 
time. Unchilled samples; internal temperatures, 38 to 40°C. Treatment solution at ambient 
temperature. In some tests application of antimicrobial made one minute before application of 
bacterial inoculation. Storage study after treatment with 1minute dip and storage. Storage study at 7°C; 
measurement of naturally occurring pseudomonades and psychrotrophs. Measurement of log 
reductions on log units/g relative to water-dip control on unchilled samples treated by dipping for 
1 minute into 200 ppm PAA after inoculation. 
Results and conclusions: log unit reductions of 0.04 (Salmonella), 0.32 (Campylobacter) 0.63 (E. coli 
O157) over control. 
3.5.2.3. Conclusions of studies on warm carcasses or parts with dip treatment 
Forest plots of results obtained with dip treatment of warm carcasses or parts are shown in Figures 3 
and 4. 
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Figure 3:  Forest plots of results of mean difference of bacterial counts obtained with dip treatment of warm carcasses or parts 
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Figure 4:  Forest plots of results of relative prevalence reduction obtained with dip treatment of warm carcasses or parts 
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Table 5 shows a summary of individual data sets from each study. In enumeration studies, there was a 
positive effect on E. coli (i.e. either a significant reduction of the log CFU or a reduction > 0.5 log-
units if CI were not provided) in 9/9 datasets; the mean decimal reduction (MDR) ranged between 0.7 
and 3.0 log-units. For coliforms, there was a positive effect in 8/8 studies with decimal reduction 
ranging between 1.12 and 3.25 log-units. All studies with indicator organisms, except one with E. coli 
were of high strength of evidence. No enumeration data on pathogens were provided. One study with 
low strength of evidence showed mean decimal reduction of Salmonella and Campylobacter of <0.5 
log-units; in this study the E. coli reduction was also less than in all other studies. All studies showed 
reduction over untreated control samples. 
Four prevalence studies were included in the summary graphs (with number of positive samples in the 
controls >5) and were provided only for Salmonella. The Salmonella prevalence was significantly 
reduced in 3/4 datasets; the relative prevalence reduction was >50 % in those datasets.. All prevalence 
studies were of high strength of evidence and all showed reduction over untreated control samples. 
Table 6:  Summary of results of studies on warm carcasses parts with dip treatment 
Decimal reduction Coliforms E. coli Salmonella Campylobacter 
Enumeration studies, confidence interval provided 
Statistically significant reduction 8(0*) 8(0*) 0 0 
No significant effect 0 0 0 0 
Significant increase 0 0 0 0 
Enumeration studies, confidence interval not provided 
MDR > 0.5 0 1(0*) 0 0 
-0.5<MDR<0.5 0 0 1(0*) 1(0*) 
MDR < -0.5 0 0 0 0 
Prevalence studies 
Statistically significant reduction 0 0 3(0*) 0 
No effect 0 0 1(0*) 0 
* number of studies out of the total where water control was applied 
 
3.5.3. Treatment group 3: studies on effects in chiller baths 
3.5.3.1. High strength of evidence studies on effects in chiller baths 
Paper 6 (Bauermeister et al., 2008b) 
Set up: 85 ppm PAA was evaluated for effectiveness compared with the 30-ppm chlorine treatment in 
a commercial setting. In this trial, 100 broiler carcasses were sampled for Salmonella and 
Campylobacter spp. prior to chilling and 100 carcasses were sampled after chilling. In all, 400 
carcasses were sampled using 85 ppm of PAA in the chiller and 400 carcasses were sampled using the 
chlorine treatment.  
Results and conclusions: PAA at 85 ppm reduced Salmonella-positive carcasses from 30.5 % to 2.5 % 
on exiting the chiller, i.e. a 91.8 % relative prevalence reduction. Treatment with 30 ppm of chlorine 
resulted in a 57 % relative prevalence reduction. Additionally, PAA gave a relative prevalence 
reduction of Campylobacter–positive carcasses exiting the chiller of 43 % while chlorine resulted in a 
13 % relative prevalence reduction.  
Paper 9 (Dankert, 2011) 
Set up: The study represented an industrial investigation of reduction of natural contamination by 
supplementing chilling bath in three production lines with 8 to 30 ppm PAA for 45 to 90 minutes. A 
total of 60 pre-chill carcasses for each of the lines were investigated and compared to 60 post-chill 
carcasses by quantitatively analysed for E. coli and qualitatively for Salmonella. 
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Results and conclusions: The study demonstrated a reduction from 2.05 to 0.63 log units/g E. coli. The 
prevalence of Salmonella was reduced from 37.2 % to 1.6 %, corresponding to a 95.5 % relative 
prevalence reduction. 
Paper 13 (FMC, 2009) 
Setup: Industrial study separated in 4 trials - #1; #3,-#5 for investigation of the reduction of natural 
contamination of pathogens (Salmonella and Campylobacter) or indicator organisms as coliforms and 
E. coli. Treatments were applied by adding PAA to the chilling tanks in variable concentrations. 
Different chilling tanks placed in different positions at the slaughter line were included. Sampling at 
identical point on days without treatment served as controls. 
#1 treatment in final chiller bath with PAA concentration between 60 and 90 ppm. Samples were 
investigated qualitatively for Salmonella and Campylobacter. 
#3 treatment in two final chillers (between 45 – 60 ppm) performed on two lines over three days. 
Samples were investigated quantitatively for coliforms and E. coli and qualitatively for Salmonella. 
#4 treatment in the pre-chiller tank (105 ppm) performed at over two days. Ten carcasses were 
selected for investigation before entering the pre-chill tank and 10 carcasses were selected after exit 
from the final chiller. At day two 8 of 10 carcasses selected post-treatment were identical with those 
selected pre-treatment. Samples were investigated quantitatively for coliforms and qualitatively for 
Salmonella and Campylobacter. 
#5 treatment in a series of three chillers; 50 ppm PAA was add to the last chiller – turkey plant. 
Eight samples were collected randomly before entering the chiller and 10 samples after chilling. 
Similar samples, collected from chilling system without added PAA, served as control. Samples were 
investigated quantitatively for coliforms and E. coli and qualitatively for Salmonella. 
Results and conclusions: 
#1 The results showed a relative prevalence reduction by PAA treatment of Salmonella at 97.5 % 
(from 62.1 % to 1.6 %) and Campylobacter at 96.6 % (from 79.3 % to 3.1 %). When compared to the 
reduction obtained during chilling without PAA at 33 % and 19 % respectively, the relative prevalence 
reduction was 98 % and 96 %. 
#3 The results showed a reduction of coliforms (line1/line2) from 2.22 and 0.85 log units/g to 
below the detection limit and of E. coli from 1.97 and 0.53 log unit/g to below the detection limit. At 
the first line Salmonella was reduced from a prevalence of 26.7 % to 3.3 % (87.5 % relative 
prevalence reduction) by the treatment whereas at the second line the prevalence declined from 32.7 % 
to 1.2 % (96.4 % relative prevalence reduction). 
#4 The contamination level of coliforms before treatment was 0.87 and 1.24 log unit/g at day 1 
and 2, respectively. After treatment the level was 0.89 and 0.67 log units/g, respectively, which 
documented a growth of coliforms at day 1 and a log reduction at 0.57 at day 2. Also the level of 
Salmonella increased at day 1 whereas it declined at day 2 from a prevalence of 40 % to a prevalence 
of 20 % (relative prevalence reduction of 50 %). The relative prevalence reduction for Campylobacter 
was 83 % (from 60 % to 10 %) at day 1 and 100 % (from 10 % to zero) at day 2. 
#5 The results showed a reduction of coliforms from 2.87 log unit/ml before chilling to below the 
detection limit after chilling. Similarly, the level of E. coli decline from 2.54 log units/ml before 
chilling to below detection limit after chilling. The study also demonstrated a reduction by chilling 
without treatment with PAA. By including these data the efficiency of PAA over the control was 2.87 
and 2.54 log units/ml for coliforms and E. coli respectively. 
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The prevalence of Salmonella was reduced from 75 % to 10 % (87 % relative prevalence reduction) by 
treatment of PAA whereas there was a reduction from 100 % to 20 % (80 % relative prevalence 
reduction) in the control system. 
Paper 23 (Vadhanasin et al., 2004)   
This study is included assuming that a 250 ppm concentration can be considered as in line with 230 
ppm threshold. 
Set up: In an experimental intervention in commercial poultry plants, 250 ppm PAA was added to 
chiller water; results were compared with historical controls with chiller water with unspecified (low*) 
levels of chlorine. Chiller temperature was 4 to 15 °C, and chiller duration 45 to 50 minutes. 25 g of 
“meat” from carcasses was sampled and analysed for Salmonella by presence/absence testing. 
Results and conclusions: Salmonella prevalence in carcasses from chillers with water with 
“unspecified low levels of chlorine” was 22.7 %, although sampled only after treatment. Therefore no 
relative prevalence reduction could be calculated; this was reduced to 5 % by addition of PAA. 
Statistical analysis was stated to be by t-test, although this test can be applied to count data, but not to 
presence/absence data. Medium strength of evidence studies on effects in chiller baths. 
3.5.3.2. Medium strength of evidence studies on effects in chiller baths 
Paper 5 (Bauermeister et al., 2008a) 
Set up: This was a storage study in a simulated chiller. Five hundred naturally contaminated carcasses 
were collected after slaughter and processing. These carcasses (100 for each treatment) were treated 
with 100 ppm, 150 ppm, 200 ppm PAA, 30 ppm chlorine and untreated water for 2 hours at chill, 4°C. 
Carcasses were not inoculated and counts of E. coli and coliforms were measured at day 1, 7, 10 and 
15 after treatment. 
Results and conclusions: By day 1, the number of E. coli was only lower, in samples treated with 150 
and 200 ppm PAA compared to water treated samples. Thus the E. coli counts (log CFU) were 0. 57 
log units lower (for 150 ppm) and 1.11 log units lower (for 200 ppm). Also for coliforms only samples 
treated with 150 ppm and 200 ppm had lower counts than was seen in water treated samples. Thus the 
coliform counts were 0.46 log and 1.14 log units lower than the counts seen in water treated samples. 
By day 7, there were no differences noted in the E. coli or coliforms among any of the treatments 
tested. 
Comment: This result raises the question as whether Gram-negative bacteria are only sublethally 
injured by PAA under the conditions used in the experiment. 
Paper 12 (Ecolab, 2001) 
Set up: Pilot study with naturally-contaminated samples that were analysed by quantification of 
coliforms and E. coli. The objective was to evaluate the effect of PAA in relation to reduction of 
spoilage or decay caused by bacteria, but in this context the occurrence of coliforms and E. coli were 
evaluated as indicators for pathogen contamination. The effect of chilling with 30 ppm PAA and the 
combination of chilling and spraying, as described above, were evaluated by comparing to 
chilling/spraying with water.  
Results and conclusions: The results, showed for chilling only, a reduction of contamination level of 
coliforms at 1.27 log units after treatment with PAA compared to a reduction at 0.60 log units after 
chilling with water. For E. coli the reduction was 1.37 log after chilling with PAA and 0.56 log units 
after spraying with water. The improved efficacy of PAA over water was 0.67 log units for coliforms 
and 0.81 log units for E. coli. 
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
39 EFSA Journal 2014;12(3):3599 
After combination of chilling and spraying, the results showed a reduction of contamination level of 
coliforms at 1.31 log units after treatment with PAA compared to a reduction at 0.78 log units after 
treatment with water. For E. coli the reduction was 1.44 log units after treatment with PAA and 0.85 
log units after treatment with water. The improved efficacy of PAA compared to water was 0.53 log 
units for coliforms and 0.59 log units for E. coli. 
3.5.3.3. Low strength of evidence studies on effects in chiller baths 
Paper 5 (Bauermeister et al., 2008a) 
Setup: The ability of different PAA levels to reduce Salmonella and Campylobacter on inoculated 
samples has been compared to levels of chlorine. 100 broiler carcasses were obtained from 
commercial processing facility pre-chiller. 40 were inoculated with S. Typhimurium and 40 with C. 
jejuni followed by 10 minute attachment time. Carcasses were placed in the assigned treatment. 
Treatments were 25, 100, 200 ppm PAA, or 30 ppm chlorine for one hour at 4 C.  
Results and conclusions: The study showed that all PAA levels reduced the CFU/sample of 
Salmonella more than the reduction obtained by using 30 ppm chlorine. The reduction in Salmonella 
counts at 25 ppm, 100 ppm and 200 ppm compared to chlorine treated samples was 0.9, 1.2 and 1.3 
log units, respectively. The reduction in Campylobacter counts at 25 ppm, 100 ppm and 200 ppm 
compared to chlorine treated samples was 0.4, 0.3 and 0.8 log units, respectively. Thus only high 
levels (200 ppm) of PAA reduced the Campylobacter count significantly more than did 30 ppm 
chlorine. 
Paper 15 (Hochmuth, 2000) 
Set up: Previously frozen chicken wings (livers are not considered) were inoculated with Salmonella 
Typhimurium or E. coli by dipping for 5 sec followed by 5 minutes attachment time. Five replicates 
were used for each condition. These samples were treated with 30 ppm PAA or water at 4 ± 2 °C for 
60 min. 
Results and conclusions: The Salmonella and E. coli counts on chicken wings were 0.32 and 1.20 log 
units lower on PAA treated carcasses compared to water treated samples.  
3.5.3.4. Conclusions of studies on effects in chiller baths 
Forest plot of results obtained with chiller baths are shown in Figures 5 and 6. 
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Figure 5:  Forest plots of results of mean difference of bacterial counts obtained with chiller baths. 
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Figure 6:  Forest plots of results of relative prevalence reduction obtained with chiller baths 
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Table 7 shows a summary of individual data sets from each study. In enumeration studies, there were 
positive effects on E. coli (i.e. either a significant reduction of the log CFU or a reduction > 0.5 log-
units if CI were not provided) in 14/19 datasets; the mean decimal reduction (MD) ranged between 0.4 
and 2.0 log-units. For coliforms, there was a positive effect in 9/22 studies with decimal reduction 
ranging between 0.3 and 2.4 log-units. All studies with indicator organisms were of high strength of 
evidence except four of medium strength and one of low strength, twelve studies showed significant 
reduction over water treated control samples. For Salmonella, positive effects were observed in 3/4 
datasets with mean decimal reduction ranging between 0.3 and 1.3 log-units. For Campylobacter, 
positive effects were observed in 1/3 datasets, even though all datasets indicated mean decimal 
reduction values ranging between 0.3 and 0.8 log-units. All pathogen studies were of low strength of 
evidence, five studies showed significant reduction over water treated control samples. 
Eight prevalence studies were included in the summary graphs (with number of positive samples in the 
controls >5) and five were provided for Salmonella and three for Campylobacter. The Salmonella 
prevalence was significantly reduced in 4/5 datasets; the relative prevalence reduction was >50 % in 
all these datasets. All prevalence studies were of high strength of evidence and all but three showed 
reduction over water treated control samples. 
Table 7:  Summary of results of studies with chiller baths 
Decimal reduction E. coli Coliforms Salmonella Campylobacter 
Enumeration studies, confidence interval provided 
Statistically significant reduction 14 (9*) 9(3*) 1* 0 
No significant effect 4(3*) 10(8*) 0 0 
Significant increase 1* 3* 0 0 
Enumeration studies, confidence interval not provided 
MDR> 0.5 0 0 3* 1* 
-0.5<MD<0.5 0 0 0 2* 
MDR< -0.5 0 0 0 0 
Prevalence studies 
Statistically significant reduction 0 0 4(2*) 3(2*) 
No effect 0 0 1* 0 
* number of studies out of the total where water control was applied. 
 
3.5.4. Treatment group 4: studies on chilled carcasses or parts with dip treatment 
3.5.4.1. Medium strength of evidence studies on chilled carcasses or parts with dip treatment 
Paper 17 (Nagel et al., 2013) 
Set up: 20 broiler carcasses per treatment conventionally processed at pilot scale facility. Carcasses 
chilled on ice for 24 hours before inoculation of each carcass with Salmonella and Campylobacter 
cultures and allowed to stand for 20 minutes before treatment. Treatment in commercial post-chill dip 
tank at 4 ± 2°C with a 20 second dwell time. Two PAA treatments of 400 and 1 000 ppm and water 
only treatment. 
Results and conclusions: log reductions of 1.3/1.4 for Salmonella, and 1.25/1.35 for Campylobacter 
over water control, dependent on concentration of PAA (400/1 000 ppm respectively. 
Paper 10 (Del Rio et al., 2007a)  
Set up: Laboratory study with natural contaminated samples and quantitative analysis of 
Enterobacteriaceae and coliforms. As samples were transported from the plant to the laboratory in an 
ice chest and stored at 3 °C ± 1 °C for no longer than 1 h the study was recognized as an evaluation of 
the efficacy of PAA applied for treatment of chilled samples. Effect of dipping chicken legs for 15 min 
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in 220 ppm peroxyacids; dipping in tap water (water-dipped control). Samples were evaluated for 
microbiological quality, pH values, and hedonic scores, after 0, 1, 3 and 5 days of storage. 
Results and conclusions: Compared to water treated samples, a reduction in Enterobacteriaceae as well 
as coliforms was identified both immediately after treatment and in the following days. The log 
reduction of Enterobacteriaceae was 0.25 immediately after treatment and increased to 2.21 after three 
days of storage; after five days the effect was declining showing 1.66 log reduction of 
Enterobacteriaceae . For coliforms the log reduction was 0.30 immediately after treatment and 1.94 
after three days of storage. After five days a 1.20 log reduction was demonstrated for coliforms. 
3.5.4.2. Low strength of evidence studies on chilled carcasses or parts with dip treatment 
Paper 16 (Mehyar et al., 2005) 
Set up: Chicken wing parts (drumettes) obtained from commercial processing plant after defeathering 
inoculated with strains of Escherichia coli O157:H7, Campylobacter jejuni, and a cocktail of three 
strains of Salmonella enterica, by two methods:. Firstly, by dipping into a culture for 15 seconds then 
allowing to drain for 15 minutes; secondly, by treatment with 200 ppm PAA (formula containing 
octanoic acid) by dipping for 1 minute in treatment or water followed by 30 second drain time. 
Unchilled samples; internal temperatures, 38 to 40°C. Treatment solution at ambient temperature. In 
some tests application of antimicrobial was made one minute before application of bacterial 
inoculation. Storage study after treatment with 1 minute dip and storage. Storage study at 7°C. 
Occurrence of naturally-occurring pseudomonades and psychrotrophs at 7, 24, 22 and 120 hours also 
assessed Measurement of reductions inn log units/g relative to water-dip control on unchilled samples 
treated by dipping for 1 minute into 200 ppm PAA after inoculation. 
Results and conclusions: For comparisons of log reductions in cfu/g relative to water-dip control on 
unchilled samples treated by dipping for 1 minute into 200 ppm PAA after inoculation log unit 
reductions of 0.04 (Salmonella), 0.32 (Campylobacter) and 0.63 (E. coli O157) over control. were 
recorded. For experiments on samples treated by dipping for 1 minute into 200 ppm before inoculation 
reductions of 0.8, 0.3 and 0.5 were recorded for Salmonella, Campylobacter and E. coli O157 
respectively; for application of PAA both before and after inoculation the reductions were 1.0 for 
Salmonella, and 0.9 for Campylobacter (no results for E. coli O157 were provided). Although not 
relevant for this assessment, log reductions of between 0.2 and 2.27 for psychotrophs and 
pseudomonads also recorded for different exposure times. 
Paper 20 (Rodrigues et al., 2011) 
Set up: Chicken carcasses were purchased at a local market and split into halves. Carcass halves were 
inoculated by spray with S. Typhimurium or C. jejuni. The level of inoculation was not clearly 
specified. Inoculated carcasses were let rest for 1 hour. 20 carcass halves were subjected to different 
treatments (10 carcasses on each of 2 days); control was city water (unspecified level of residual 
chlorine). Treatment was aimed at a PAA concentration of 500 ppm, measured residual after 2 and 5 
min were 560 and 520 ppm PAA, respectively. Halves were placed in bins containing 10 litres of 
treatment solution with hand agitation for either 2 or 5 minute treatments, baths were kept chilled by 
use of icepacks. Only results after 2 minutes have been considered, as the application specifies a 
maximum duration of 3 minutes. 
After the intended contact time, residual PAA was neutralised with a sodium thiosulphate solution and 
halved carcass were sampled using rinsing in city water. Rinsates were serially diluted for analysis by 
plate count on selective media without resuscitation. 
Results and conclusions: Data generated from the laboratory experiments demonstrated 1.57 log units 
reduction of S. Typhimurium and 3.00 log units reduction of C. jejuni above the effect of water. Both 
effects were highly significant. 
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Paper 7 (Chantarapanont et al., 2004)  
Set up: The objective was to determine the effect of chlorine, acidified sodium chlorite, and peracetic 
acid treatments on viable Campylobacter jejuni located at various depths within follicles or folds of 
chicken skin. Skin samples were inoculated with C. jejuni. Water control and two PAA treatments (40 
and 100 ppm) were used for 2 and 15 min exposure. Exposure was at room temperature. 
Results and conclusions: PAA treatment resulted in approximately a 1.05 log units decrease per square 
cm over the water control treatment when used at 100 ppm for 15 min and no significant decrease 
when used at 40 ppm for 2 min. 
Paper 8 (Dankert, 2010)  
Set up: In this laboratory study the efficacy of PAA against E. coli and Salmonella Typhimurium  
inoculated on parts or whole poultry carcasses obtained at retail. PAA concentrations were 0, 20, 40, 
80 ppm respectively. 
Results and conclusions: The reduction in surviving colonies of E. coli and Salmonella ranged from 
33-90 % (0.17 to 0.98 log unit over control) for E. coli and 57-86 % (0.36 to 0.85 log unit over 
control) for Salmonella. The reductions increased with increased PAA concentration. 
Paper 11 (Del Rio et al., 2007b) 
Set up: Laboratory study with high level (6.93 and 6.82 log units/g, respectively) inoculation of 
samples with Salmonella Enteritidis and Escherichia coli. As samples were transported from the plant 
to the laboratory in an ice chest and stored at 3 °C ± 1 °C for no longer than 1 h the study was 
recognized as an evaluation of the efficacy of PAA applied for treatment of chilled samples. Effect of 
dipping chicken legs for 15 min in 220 ppm peroxyacids ; dipping in tap water (water-dipped control). 
Samples were evaluated for microbiological quality, pH values, and hedonic scores, after 0, 1, 3 and 5 
days of storage. 
Results and conclusions: Compared to water treated samples, a small log reduction of S. Enteritidis at 
0.03 was observed immediately after treatment. The relative log reduction of this pathogen increased 
to 0.14; 1.11 and 1.51 during the following 1, 3 and 5 days of storage. For E. coli the immediately log 
reduction was 0.44 increasing to 0.59; 1.02 and 1.78 during the following 1, 3 and 5 days of storages.  
3.5.4.3. Conclusions of studies on chilled carcasses or parts with dip treatment 
Forest plot of results obtained with dip treatment of chilled carcasses or parts are shown in Figure 7. 
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Figure 7:  Forest plots of results of mean difference of bacterial counts obtained with dip treatment of chilled carcasses or parts.
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Table 7 shows a summary of individual data sets from each study. In enumeration studies, there were 
positive effects on E. coli (i.e. either a significant reduction of the log CFU or a reduction > 0.5 log-
units if CI were not provided) in 7/11 datasets; the mean decimal reduction (MD) ranged between 0.17 
and 1.78 log-units. For coliforms, there was a positive effect in 3/4 studies with decimal reduction 
ranging between 0.30 and 1.94 log-units and for Enterobacteriaceae, 3/4 studies showed a positive 
effect ranging between 0.25 and 2.21 log-units.. All studies with indicator organisms were of low or 
medium strength of evidence, ten studies showed significant reduction over water treated control 
samples. For Salmonella, positive effects were observed in 10/14 datasets with mean decimal 
reduction ranging between 0.14 and 1.57 log-units. For Campylobacter, positive effects were observed 
in 7/8 datasets, with mean decimal reductions values ranging between 0.30 and 3.00 log-units. All 
pathogen studies, except one of medium, were of low strength of evidence. Seven studies showed 
significant reduction over water treated control samples. 
No prevalence studies were provided for this treatment group. 
Table 8:  Summary of results of studies with dip treatment of chilled carcasses or parts 
Decimal reduction E. coli Coliforms Salmonella Enterobacteriaceae Campylobacter 
Enumeration studies, confidence interval provided 
Statistically significant reduction 4* 0 4(3*) 0 1 
No significant effect 0 0 1* 0 0 
Significant increase 0 0 0 0 0 
Enumeration studies, confidence interval not provided 
MDR > 0.5 3 3* 6(2*) 3* 6(2*) 
-0.5<MDR<0.5 4 1* 3 1* 1 
MDR < -0.5 0 0 0 0 0 
Prevalence studies 
Statistically significant reduction 0 0 0 0 0 
No effect 0 0 0 0 0 
* number of studies out of the total where water control was applied. 
 
3.6. Conclusions 
 Evaluations could only be performed for meat classified as poultry (assumed to be chicken) 
and for chicken carcasses and parts. No data were provided for other poultry species, with the 
possible exception of a single study involving turkey meat. 
 Studies were classified as of high or medium strength of evidence if they used naturally-
contaminated samples on industrial or pilot scale, respectively; 6/17 studies provided data on 
the reduction of bacteria over water controls. 
 The statistical analysis of the data in the published studies was of variable quality; where 
possible confidence intervals were calculated by the Biological Hazard Panel. The reduction 
of bacterial counts was considered relevant if the confidence interval did not include zero 
(statistically significant), or, following expert judgement (when confidence intervals were not 
available), if the mean decimal reduction was greater than 0.5 log-units. 
 There was consistent evidence (16/17 data points) for substantial reductions (1-3 log-units 
over untreated controls) in the counts of E. coli and coliforms when treating warm carcasses 
by dipping into PAA solutions. 
 Data on pathogen reduction following this treatment were limited; the prevalence reduction of 
Salmonella was statistically significant for 3/4 data points (the relative prevalence reduction 
ranged between 91 % to 95 %). 
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 Spraying of warm carcasses was less effective than dipping in reducing indicator organisms; 
15/25 data points showed relevant reductions of indicator organisms (0.5-1.5 log-units). The 
prevalence reduction of Salmonella was statistically significant in 6/9 studies (the relative 
prevalence reduction ranged between 28 % to 87 %). 
 There was evidence for a reduction of counts of Salmonella and Campylobacter and indicator 
organisms when treating chilled carcasses or parts by dipping; the effects were considered 
relevant for 30/41 data points. The studies provided were categorised as having low or 
medium strength of evidence. The effect of PAA treatment (0-2 log-units) was less than for 
warm carcasses.  
 There was evidence for a reduction of E. coli (0.5-2 log-units) after the addition of PAA to 
chiller baths; the effects were considered relevant for 14/19 data points. The effects on 
coliform bacteria were less consistent; the effects were considered relevant for 9/22 data 
points. Data on reduction of the number of Salmonella and Campylobacter following this 
treatment was limited; the effects were considered relevant for 5/7 data points. The prevalence 
reduction of Salmonella and Campylobacter was statistically significant in 7/8 data points 
from studies of high strength of evidence (the relative prevalence reduction ranged between 
30 % to 99 %). 
 The study designs were heterogeneous. Further integration of data and evaluation of the effect 
of different processing parameters (PAA concentration, contact time, temperature, pH etc.) 
was therefore not possible. 
 The efficacy of PAA treatment after storage of treated poultry carcasses and products was 
only investigated in two studies with naturally-contaminated samples, and these gave 
conflicting results. Such studies, are required in the EFSA guidelines to evaluate whether 
micro-organisms are truly inactivated or only sublethally injured. 
Recommendations 
 Further high strength of evidence studies with pathogens should be undertaken, particularly 
for Campylobacter.  
 The effects of PAA treatment needs to be regularly evaluated in poultry processing plants 
using PAA solutions as a decontaminating agent. 
 Monitoring of the concentration of the decontaminating substance in the working PAA 
solution should be included in HACCP plans. 
 As mentioned in the EFSA guidelines (EFSA Panel on Biological Hazards (BIOHAZ), 2010), 
treated carcasses should also be examined at the end of shelf life to ensure that the level of 
contamination remains low. 
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4. The potential emergence of reduced susceptibility to biocides and/or resistance to 
therapeutic antimicrobials linked to the use of the substance  
4.1. Submission by the Applicant (1) 
In relation to testing for the possibility of the development of resistance to the compound, or of 
resistance to therapeutic antibiotics, the Applicant does not appear to have undertaken any of the tasks 
outlined in sections 1.1. and 1.2. of the EFSA guidelines (EFSA Panel on Biological Hazards 
(BIOHAZ), 2010). 
The key points of their submission in relation to the possibility of resistance development fall under 
the clause in the EFSA guidelines „the Applicant may apply for approval based on the history of 
apparent safe use. If data are available from application of the product for uses other than removal of 
food surface contamination, they could be submitted for consideration‟. 
4.1.1. Information provided in support of the above: 
The Applicant has stated that: „there appear to be no reports of bacterial populations developing 
resistance to PAA disinfectants‟, for the following reasons:  
„PAA disrupts cellular activity by oxidizing the cell membrane and indiscriminately oxidizing cellular 
components. Its mode of action makes it difficult to conceive how resistance would develop due to the 
treatment of poultry carcasses. As discussed in the dossier, PAA is not like an antibiotic that blocks a 
specific metabolic pathway. PAA solutions are widely used disinfectants. If any resistance or 
hardening of bacteria to PAA solutions, it would have occurred in response to use as a surface 
disinfectant. We do not believe that any data or published studies exist that examines the possibility of 
resistance by bacteria to PAA solutions and are not aware of any study that indicates a reduction of 
effectiveness‟. Because of its mode of action it seems very improbable that use of PAA would lead to 
transferable genetic components that would provide resistance to antibiotics‟.  
„There seems to be a very low probability that the use of PAA for pathogen reduction on poultry 
carcasses or parts would increase the risk of development of antimicrobial resistance to the 
disinfectant itself and an extremely low probability that it would contribute to the development of 
resistance to therapeutic antibiotics‟.  
„HEDP does not have antimicrobial properties so it is not expected to promote antimicrobial 
resistance‟.  
‘Safe use in other domains’  
„Our application for the approval of PAA in poultry production incorporates a range of poultry-
carcass-contact uses, but the solutions have been used in many other domains for decades‟. See 
Section 2 of the dossier and the references cited therein (ECETOC, 2001; EPA, 1993, 2009) and the 
EU Directive 98/8/EC
11
 and EC Regulation 1451/2007
12
. 
The history of safe use of PAA is not only in other domains - the safety of PAA has been 
demonstrated on poultry in the U.S. and in other countries over the past decade. We also note that in 
2008 the EU BIOHAZ panel: “….concluded that despite a long history of use, there are currently no 
published data to conclude that the application of chlorine dioxide, acidified sodium chlorite, 
trisodium phosphate or peroxyacids to remove microbial contamination of poultry carcasses at the 
proposed conditions of use will lead to the occurrence of acquired reduced susceptibility to these 
                                                     
11  Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal 
products on the market 
12 Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme 
referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of 
biocidal products on the market 
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substances. Similarly, there are currently no published data to conclude that the application of 
chlorine dioxide, acidified sodium chlorite, trisodium phosphate or peroxyacids to remove microbial 
contamination of poultry carcasses at the proposed conditions of use will lead to resistance to 
therapeutic antimicrobials.”  
4.2. Submission by the Applicant (2) 
A further recommendation in the EFSA guidelines is that:  
„If the product is released into the environment without neutralisation, a post-market monitoring and 
evaluation is recommended to determine the long-term effects of using the formulated product on 
selection and dissemination of acquired reduced susceptibility to biocides and/or resistance to 
therapeutic antimicrobials‟. 
4.2.1. Information provided by the Applicant 
Resistance: „Several studies have been conducted that address the question of resistance, and we 
review five of these below. However, it is important to note that PAA‟s active ingredients do not 
persist.  
„Some bacteria can develop higher minimum inhibitory (MIC) concentrations upon exposure to 
disinfectants. This may occur when disinfectants are used incorrectly at sub-lethal concentrations or 
applied before surfaces have been properly cleaned. Because of this, development of resistance is a 
significant consideration in the widespread use of surface disinfectants. However, the increases in 
MIC against disinfectants generally occur through mechanisms such as biofilm formation or biological 
pumps. These are more the result of external environmental conditions coupled with the 
microorganism‟s already existing genetic response, rather than an evolution of new intrinsic biological 
pathways. The development of increased resistance over time was studied directly by Alonso-
Hernando et al. (2009). Even in the case where multiple generations of bacteria were grown in sub-
lethal concentrations of PAA, under conditions that had the greatest chance for development of 
resistance, the MIC against PAA for the two bacterial strains studied was only raised about 10 %, far 
lower than values typically seen with antibiotic resistance, and MICs remained unaffected for the two 
other strains analyzed. These results, although relevant for repeated use of surface sanitizers on 
equipment, are not representative or equal to the conditions under which PAA is used on rinsing 
carcasses for meat safety‟.  
„Alonso-Hernando et al. (2009) also studied whether PAA and other disinfectants caused resistance to 
therapeutic antimicrobials (i.e. antibiotics). Again, multiple generations of bacteria were grown under 
sub-lethal concentrations, conditions specifically created to foster resistance. For PAA, this resulted in 
an increased MIC for some of the antibiotics tested, but the disinfectants were used repeatedly on the 
same surface area. This is representative of surface sanitizer use in a plant or hospital setting, but not 
use as a single rinse for carcasses. However, as noted in the paper, the mechanisms of resistance for 
microbes to antibiotics verses PAA (and the other disinfectants) differ greatly. This is important as the 
bacterial defence mechanisms exercised under these conditions are probably irrelevant to the 
development of intrinsic (genetic) mechanisms of bacterial resistance to antibiotic‟.  
„Geornaras et al. (2012) considered whether bacteria that are resistant to antibiotics are also less 
susceptible to disinfectants like PAA. If bacteria did utilize similar mechanisms for developing 
resistance to an antibiotic and PAA, then those same resistant bacteria should have reduced sensitivity 
to both PAA and the antibiotics. When this research was conducted, antibacterial resistant and non-
resistant strains of bacteria did not exhibit increased resistance to disinfectants like PAA, suggesting 
different mechanisms are employed by bacteria for protection against disinfectants verses antibiotics‟.  
„In a recent review by Møretrø et al. (2012) there was no evidence for increased antimicrobial 
resistance of Salmonella to any of the currently used disinfectants in the poultry industry, and even 
when resistance was reported in wild type serovars, the MIC was still below recommended user 
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concentrations for all the disinfectants currently used in the industry including PAA. Even in human 
medicine the development of antimicrobial resistance to disinfectants is still poorly understood, 
especially for non-spore forming bacteria. Humphreys et al. (2013) found PAA to be a viable 
alternative to disinfection with chlorine bleach for disinfection in hospital settings despite its already 
widespread applications of PAA. There is no evidence to support an increased risk or incidence of the 
development of antimicrobial resistance to PAA in the meat industry since the first patent was 
obtained in 1950‟. 
4.3. Evaluation from EFSA Biological Hazards (BIOHAZ) Panel (3) 
The Panel has assessed the information provided by the Applicant as summarised in sections 4.1. and 
4.2. above. 
4.3.1. Development of resistance 
Although no direct experiments have been conducted to test for the potential emergence of acquired 
reduced susceptibility to biocides and/or resistance to therapeutic antimicrobials following the use of 
PAA, evidence provided as to the history of safe use of PAA is sufficient to meet the requirements of 
EFSA Guidelines of 2010 cited above, in that „the applicant may apply for approval based on the 
history of apparent safe use‟.  
4.3.2. Post-market evaluations 
As with section 4.3.1. above, no direct post-market evaluations have been undertaken, Nevertheless 
the information provided by the Applicant, and in that „PAA used by poultry production facilities is 
neutralized and does not reach the environment. PAA solutions degrade before discharge of 
wastewater‟ is indicative that a targeted post-market evaluation of the potential persistence of PAA the 
environment may not be necessary. 
4.4. Conclusions 
 On the basis of the information provided by the Applicant, the emergence of acquired reduced 
susceptibility to biocides and/or resistance to therapeutic antimicrobials following the use of 
PAA is considered unlikely. 
4.5. Recommendations 
 Laboratory studies should be undertaken to confirm that reduced susceptibility to biocides 
and/or resistance to therapeutic antimicrobials following the use of PAA does not occur.  
 Post-marketing surveillance for resistance in both pathogenic and commensal bacteria should 
be included in HACCP plans should PAA be applied for decontamination of poultry carcasses. 
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5. The risk related to the release of the processing plant effluents, linked to the use of the 
substance, into the environment 
A typical poultry plant slaughters 200 000 chickens per day. In this process 5.8 million litres of 
wastewater is generated according to the Applicant. The daily amount of 378 litres of concentrated 
peroxyacetic acid solution contains: 67.4 kg peroxyacetic acid, 25.3 kg hydrogen peroxide, 235.8 kg 
acetic acid and 3.8 kg HEDP according to the Applicant. The first three compounds of this list are 
readily degradable in a sewage water treatment system of the poultry plant. Acetic acid and hydrogen 
peroxide are common metabolic intermediates and degrade quickly via the citric acid cycle or catalase 
activity. Peroxyacetic acid is in chemical equilibrium with hydrogen peroxide and acetic acid 
(ECETOC, 2001). Therefore, it will therefore decompose quickly in a sewage treatment system. The 
same holds true for octanoic acid. Hydrogen peroxide and peroxyacetic acid or peroxyoctanoic acid 
are highly reactive chemically unstable disinfectants and therefore the development of antibiotic 
resistance is not considered an issue. The reduction of these compounds by peroxidases is a common 
mechanism in aerobic organisms since it is vital for survival in the presence of oxygen. Catalase is a 
common enzyme, which can also remove hydrogen peroxide. 
As acetic acid, peroxyacetic acid, octanoic acid, peroxyoctanoic acid and hydrogen peroxide are 
effectively neutralized before discharge of wastewater, tests regarding development and dissemination 
of acquired reduced susceptibility of environmental microorganisms are likewise not considered 
necessary. Similarly, on the surface of poultry carcasses themselves, the active ingredients of PAA 
have a measured lifetime of a few minutes, so there are no peroxyacids to measure on the product after 
leaving the processing plant.  
In contrast, HEDP will not be biodegraded in a sewage treatment system. A concentration of 
3800/5.81= 650 µg/L wastewater can flow into the sewage treatment system. HEDP can be partially 
removed in sewage treatment systems by sorption to the sludge. This depends on the specific 
conditions in the system and removal percentages of HEDP vary around 50 % (HERA, 2004). The 
wastewater dilutes when it flows into a river or a lake. Both big and small poultry plants produce the 
similar concentration of HEDP in their wastewater but the dilution factor will be larger when a small 
plant pollutes a big river. The default dilution factor for sewage from treatment plants is a factor 10. 
(ECB, 2003) This yields a final Predicted Environmental Concentration (PEC) of 
650×10 %×50 %=32.5 µg/L in surface water. 
A preliminary guideline for surface water quality (No Effect Concentration) was derived for HEDP in 
literature review (Oste et al., 2009) to be 1 µg/L. This follows from the No Observed Effect 
Concentration (NOEC) of a Daphnia magna reproduction test of 100 µg/litre using a safety factor of 
100 (Oste et al., 2009). Preliminary surface water quality guidelines may be replaced in the future by a 
full-scale environmental risk assessment to be performed according to the European guidelines (ECB, 
2003). HEDP can chelate metals and therefore reduce the availability of essential metals in a 
reproduction test. Nevertheless, the essential metals are added in excess in a reproduction test. The 
metal availability in a natural freshwater system, amended with water from a sewage treatment system, 
might be better or worse than that in a reproduction test. As a reasonable worst-case estimate, it is 
assumed that the metal availability in a freshwater system is similar to that in a reproduction test. This 
means that the relatively low NOEC of the Daphnia magna reproduction test can be used for the risk 
evaluation. Consequently, the PEC/NEC ratio is 32.5 indicating a risk for the environment of the use 
of HEDP in poultry plants. Preliminary guidelines are often overprotective because of lack of 
knowledge. HEDP is a high production volume chemical which is used in, e.g. soaps. 
5.1. Conclusions 
At this stage, the emission of HEDP from a poultry plant via a sewage treatment system into the 
freshwater environment cannot be considered safe a priori. Therefore, site-specific considerations are 
needed to evaluate the possible risk of the emission of HEDP in each poultry plant. A dedicated on-
site sewage treatment system might be able to remove a larger percentage of HEDP. The dilution 
factor for sewage from treatment plants might be higher than the standard factor 10, when a small 
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poultry plant pollutes a big water body. The annual average dilution factor will not be appropriate 
since the susceptible crustaceans (e.g. Daphnia magna) reproduce in summertime when the flow of 
rivers and streams often is minimal. 
CONCLUSIONS AND RECOMMENDATIONS 
GENERAL CONCLUSIONS: 
 This Opinion deals with the evaluation of the safety and efficacy of mixtures containing 
peroxyacetic acid (PAA) as active ingredient, for reduction of pathogens on poultry carcasses 
and meat, under the usage conditions as specified by the Applicant. These include (i) 
treatment of warm carcasses with spray treatment (PAA concentrations typically between 400-
700 ppm and spray times up to 10 seconds); (ii) treatment of warm carcasses or parts with dip 
treatment (PAA concentrations up to 2 000 ppm and contact times up to 3 minutes); (iii) 
treatment of carcasses in chiller baths (PAA concentrations up to 230 ppm and contact times 
between 1-2 hours) and (iv) treatment of chilled carcasses or parts with dip treatment (PAA 
concentrations up to 2 000 ppm and contact times up to 3 minutes). In the mixtures, PAA is in 
chemical equilibrium with hydrogen peroxide and acetic acid. The mixtures also contain 1-
hydroxyethylidene-1,1-diphosphonic acid (HEDP) and some mixtures also octanoic acid and 
its reaction product peroxyoctanoic acid. 
 PAA has previously been evaluated by EFSA and other international bodies; these evaluations 
have been taken into account in this Opinion. 
ToR 1.  
The toxicological safety of the substance 
 Accepting the previous EFSA exposure scenarios (EFSA, 2005), and supplemented with more 
recent information on consumption data of poultry meat within the EU (EFSA, 2011), there 
are no toxicity concerns with regard to residues of peroxyacids as these compounds are 
unstable and break down into acetic acid and water. 
 Similarly there are no concerns in relation to residues of acetic acid and octanoic acid. 
 There are also no concerns when applying PAA using dip treatments of no more than 3 
minutes (short term) with the proposed higher concentration of the peroxyacetic acid 
solutions. 
 There are no toxicity concerns for the product stabilizer HEDP with regard to the dip 
treatment, referring to the margin of safety of 43 103 as calculated from European intake 
scenario.  
 Regarding the safety of possible reaction products of hydrogen peroxide and peroxyacids with 
lipids and proteins/amino acids of the poultry carcasses, no risk was anticipated due to the 
high instability of the peroxyacids. 
 No lipid peroxidation was identified in producer experiments when using immersion for 60 
minutes in 200 mg/L total peroxyacetic acid. The short term high concentration bath scenario 
included in the present application dossier should not cause measurable lipid peroxidation. 
ToR 2. The efficacy, i.e. does the use of the substance significantly reduce the level of 
contamination of pathogens on poultry carcasses and poultry meat 
 The studies submitted by the Applicant used a wide range of experimental designs and thus 
differed in relation to products, settings, method of application, PAA concentration, use of 
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controls, microorganisms studied, time of analysis after application, etc. All these parameters 
impacted on the observed efficacy. Comparison beyond treatment groups was not possible.  
 Evaluation could only be performed for tests on chicken carcasses and parts, with one possible 
exception no data were provided on other poultry species. 
 The statistical analysis of the data in the published studies was of variable quality, where 
possible confidence intervals were calculated by the Biological Hazard Panel. The reduction 
of bacterial counts was considered relevant if the confidence interval did not include zero 
(statistically significant), or, following expert judgement (when confidence intervals were not 
available), if the mean decimal reduction was greater than 0.5 log-units. 
 There was consistent evidence for a relevant impact (1-3 log-units over untreated controls) of 
PAA treatment on E. coli and coliforms when treating warm carcasses by dipping. There were 
few data on reduction of Salmonella and Campylobacter for this treatment. There was 
evidence for statistically significant Salmonella prevalence reduction (the relative prevalence 
reduction ranged between 91% and 95%). 
 Spraying of warm carcasses appeared to be less effective in reducing indicator organisms than 
dipping (0.5-1.5 log-units). There was evidence for statistically significant Salmonella 
prevalence reduction (the relative prevalence reduction ranged between 28% and 87%). 
 There was consistent evidence for a relevant reduction (0.5-2 log-units) of indicator organisms 
and Salmonella and Campylobacter when treating chilled carcasses or parts by dipping, but 
the studies were of low or medium strength of evidence.  
 There was consistent evidence for a relevant impact on E. coli when adding PAA to chiller 
baths (0.5-2 log-units). The effects on coliform bacteria were less consistent. There were few 
data on reduction of the number of Salmonella and Campylobacter for this treatment. There 
was evidence for statistically significant Salmonella and Campylobacter prevalence reduction 
(the relative prevalence reduction ranged between 30% and 99%). 
 The efficacy of PAA treatment after storage of treated carcasses/products was only 
investigated in two studies with naturally-contaminated samples, and these gave conflicting 
results. Such studies are required in the EFSA guidelines to evaluate whether micro-organisms 
are truly inactivated or only sublethally injured. 
ToR 3. The potential emergence of reduced susceptibility to biocides and/or resistance to 
therapeutic antimicrobials linked to the use of the substance 
 On the basis of the safe usage information provided by the Applicant, the emergence of 
acquired reduced susceptibility to biocides and/or resistance to therapeutic antimicrobials 
following the use of PAA is considered unlikely. 
ToR 4. The risk related to the release of the slaughterhouse and/or processing plant effluents, 
linked to the use of the substance, into the environment. 
 Acetic acid, peroxyacetic acid, octanoic acid, peroxyoctanoic acid and hydrogen peroxide are 
effectively neutralized before discharge of wastewater. There is therefore no concern about 
environmental toxicity of these compounds. Likewise, tests regarding the development of 
acquired reduced susceptibility in environmental microorganisms then subsequent 
dissemination are not considered necessary. 
 On the basis of a conservative preliminary guideline for surface water quality from a literature 
review, the emission of HEDP from a poultry plant including via a wastewater treatment 
system into the freshwater environment cannot be considered safe a priori.  
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 Site-specific considerations related to dilution factors and improved efficiency of wastewater 
treatment plants, can mitigate the possible environmental risk associated with the emission of 
HEDP from individual poultry plants using PAA solutions for decontamination treatment.  
RECOMMENDATIONS 
ToR 1. The toxicological safety of the substance 
 To control residues of HEDP on poultry carcasses, monitoring of the concentration of HEDP 
in the working PAA solution should be considered in the HACCP plans.  
 A method for the determination of HEDP residues on poultry carcases, poultry meat and 
poultry meat products should be developed and validated, to further inform the risk 
assessment.  
ToR 2. The efficacy, i.e. does the use of the substance significantly reduce the level of 
contamination of pathogens on poultry carcasses and poultry meat 
 Further high strength of evidence studies with pathogens should be undertaken, in particular 
with Campylobacter. 
 Monitoring of the concentration of the decontaminating substance in the working PAA 
solution should be considered in HACCP plans. 
 As mentioned in the EFSA guidelines, treated carcasses should be examined at the end of 
shelf life to ensure that the level of contamination remains low. 
ToR 3. The potential emergence of reduced susceptibility to biocides and/or resistance to 
therapeutic antimicrobials linked to the use of the substance 
 Laboratory studies should be undertaken to confirm that reduced susceptibility to biocides 
and/or resistance to therapeutic antimicrobials following the use of PAA does not occur.  
 Post-marketing surveillance for resistance in both pathogenic and commensal bacteria should 
be considered in HACCP plans should PAA be applied for decontamination of poultry 
carcasses. 
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DOCUMENTATION PROVIDED TO EFSA 
1. Letter Ref. Ares(2013)2190494 received on 17 June 2013 including the request from the 
Commission and application dossier in electronic copy from U.S. Department of Agriculture 
(USDA) “Submission of data for the authorization of peroxyacetic acid solutions for uses to 
reduce microbial contamination of poultry carcasses”. 
2. The mandate and technical/application dossier in electronic and paper copy from U.S. Department 
of Agriculture (USDA) “Submission of data for the authorization of peroxyacetic acid solutions 
for uses to reduce microbial contamination of poultry carcasses” received on 24 June 2013. 
3. Reply to EFSA‟s request for missing information on 31 July 2013. Received by EFSA from U.S. 
Department of Agriculture (USDA) on 4 September 2013. 
4. Reply to EFSA‟s request for additional data on 11 October 2013. Received by EFSA from U.S. 
Department of Agriculture (USDA) on 6 November 2013. 
5. Reply to EFSA‟s request for additional data on 27 November 2013. Received by EFSA from U.S. 
Department of Agriculture (USDA) on 17 December 2013. 
  
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
56 EFSA Journal 2014;12(3):3599 
REFERENCES  
Abraham S et al., 2011. Spectrum 
TM
/Spectrum 2000
TM
 application as an antimicrobial agent in on-line 
reprocessing systems for poultry processing plants in dip tank style applications (Facility "C"). 46. 
Abraham S, An W, Homan M, Manoley L, Johnson E and Rovison J, 2006. Summary report of on-line 
reprocessing trial using 25 parts per million of PeraSafe at Plant "A" in Arkansas. FMC 
Peroxygens, 30. 
Abraham S, An W, Homan M, Manoley L, and Rovison J, 2007. Executive summary of three on-line 
reprocessing in-plant trials using FMC-323 (Spectrum™). FMC Peroxygens, 11. 
Abraham S, Bowen M, Krueger E, Moloney L, Neal S, Rovison J, Thompson A, Williams R and 
Oxford E, 2010. Spectrum 
TM
 - Spectrum 2000
TM
 application as an antimicrobial agent in on-line 
reprocessing systems for poultry processing plants in dip tank style applications (Facility "B"). 
FMC Peroxygens, 66. 
Alonso-Hernando A, Capita R, Prieto M and Alonso-Calleja C, 2009. Adaptation and cross-adaptation 
of Listeria monocytogenes and Salmonella enterica to poultry decontaminants. Journal of 
Microbiology, 47, 142-146. 
Azanza PV, 2004. Hydrogen peroxide, Peroxyacetic acid, Octanoic acid, Peroxyoctanoic acid, and 1-
hydroxyethylidene-1,1-Diphosphonic acid (HEDP) as components of antimicrobial washing 
solution. Chemical and Technical Assessment (CTA). FAO (63
rd
 JECFA), 1-7.  
Bauermeister LJ, Bowers JWJ, Townsend JC and McKee SR, 2008a. The microbial and quality 
properties of poultry carcasses treated with Peracetic Acid as an antimicrobial treatment. Poultry 
Science, 87, 2390-2398. 
Bauermeister LJ, Bowers JWJ, Townsend JC and McKee SR, 2008b. Validating the efficacy of 
peracetic acid mixture as an antimicrobial in poultry chillers. Journal of Food Protection, 71, 1119-
1122. 
Chantarapanont W, Berrang ME and Frank JF, 2004. Direct microscopic observation of viability of 
Campylobacter jejuni on chicken skin treated with selected chemical sanitizing agents. Journal of 
Food Protection, 67, 1146-1152. 
Dankert J, 2010. Determination of the antimicrobial activity of ProtectFx (FNC 993): Pathogen 
reduction for poultry processing. 9. 
Dankert J, 2011. In-plant studies of ProtectFx antimicrobial treatments in prechill spray application 
and chiller bath. Synergy technologies, 20. 
Del Rio E, Moran-Panizo M, Prieto M, Alonso-Calleja C and Capita R, 2007a. Effect of various 
chemical decontamination treatments on natural microflora and sensory characteristics of poultry. 
International Journal of Food Microbiology, 115, 268-280. 
Del Rio E, Muriente R, Prieto M, Alonso-Calleja C and Capita R, 2007b. Effectiveness of trisodium 
phosphate, acidified sodium chlorite, citric acid, and peroxyacids against pathogenic bacteria on 
poultry during refrigerated storage. Journal of Food Protection, 70, 2063-2071. 
ECB (European Chemicals Bureau), 2003. Part II of the Technical Guidance Document on risk 
assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified 
substances, Commission Regulation (EC) No 1488/94 on risk assessment for existing substances; 
Directive 98/8/EC of the European Parliament and of the Council concerning the placing of 
biocidal products on the market, 21 pp.  
ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals), 2001. Peracetic acid 
(CAS No. 79-21-0) and its equilibrium solutions, Joint Assessment of Commodity Chemicals 
(JACC) 40. 156 pp. 
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
57 EFSA Journal 2014;12(3):3599 
Ecolab I (Ecolab Inc), 2001. Secondary direct food additive petition: The use of peroxyacetic acid, 
octanoic acid, acetic acid, hydrogen peroxide, peroxyoctanoic acid and 1-hydroxyethylidene-1,1-
diphosphonic acid as an antimicrobial agent on poultry carcasses parts and poultry organs.  
EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on biological hazards 
(BIOHAZ) on the "Evaluation of the efficacy of peroxyacids for use as an antimicrobial substance 
applied on poultry carcasses". The EFSA Journal 2005, 306, 1-10.  
EFSA (European Food Safety Authority), 2008. Scientific Opinion of the Panel on Biological Hazards 
(BIOHAZ) on Assessment of the possible effect of the four antimicrobial treatment substances on 
the emergence of antimicrobial resistance. The EFSA Journal 2008, 659, 1-26.  
EFSA Panel on Biological Hazards (BIOHAZ), 2010. Guidance on revision of the joint 
AFC/BIOHAZ guidance document on the submission of data for the evaluation of the safety and 
efficacy of substances for the removal of microbial surface contamination of foods of animal origin 
intended for human consumption. EFSA Journal 2010;8(4):1544, 32 pp. 
doi:10.2903/j.efsa.2010.1544 
EFSA Panel on Biological Hazards (BIOHAZ), 2011a. Scientific opinion on Campylobacter in broiler 
meat production: control options and performance objectives and/or targets at different stages of 
the food chain. EFSA Journal 2011;9(4):2105, 141 pp. doi:10.2903/j.efsa.2011.2105 
EFSA Panel on Biological Hazards (BIOHAZ), 2011b. Scientific Opinion on the evaluation of the 
safety and efficacy of lactic acid for the removal of microbial surface contamination of beef 
carcasses, cuts and trimmings. EFSA Journal 2011;9(7):2317, 35 pp. doi:10.2903/j.efsa.2011.2317 
EFSA Panel on Biological Hazards (BIOHAZ), 2012a. Scientific Opinion of the Panel on Biological 
Hazards on the public health hazards to be covered by inspection of meat (poultry). EFSA Journal 
2012;10(6):2741, 179 pp. doi:110.2903/j.efsa.2012.2741 
EFSA Panel on Biological Hazards (BIOHAZ), 2012b. Scientific Opinion on the evaluation of the 
safety and efficacy of Cecure® for the removal of microbial surface contamination of raw poultry 
products. EFSA Journal 2012;10(3):2612, 66 pp. doi:10.2903/j.efsa.2012.2612 
EPA, 1993. Peroxy Compounds. From: Report dated December 1993 from U.S. Environmental 
Protection Agency. http://www.epa.gov/oppsrrd1/REDs/old_reds/peroxy_compounds.pdf. 188 pp. 
EPA, 2009. Peroxy Compounds Summary Document: Registration Review. From: Report dated 
September 2009 from U.S. Environmental Protection Agency.            
http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2009-0546-0005. 106. 
FAO/WHO (Food and Agriculture Organization of the United Nations / World Health Organization), 
2008. Consultations and workshops: Benefits and risks of the use of chlorine-containing 
disinfectants in food production and food processing. Report of a joint FAO/WHO expert meeting. 
288 pp. 
FMC, 2009. Summary of poultry trial conducted by FMC. From: File properties list author as 
Abrahams.  
FSIS, OPPD and RIMD, 2012. On-line and off-line reprocessing in-plant trial data analysis. 7. 
Geornaras I, Yang H, Moschonas G, Nunnelly MC, Belk KE, Nightingale KK, Woerner DR, Smith 
GC and Sofos JN, 2012. Efficacy of chemical interventions against Escherichia coli O157:H7 and 
multidrug-resistant and antibiotic-susceptible Salmonella on inoculated beef trimmings. Journal of 
Food Protection, 75(11), 1960-1967. 
HERA (Human & Environmental Risk Assessment on ingredients of European household cleaning 
products. 144 pp), 2004. Phosphonates (CAS 6419-19-8; 2809-21-4; 15827-60-8), .  
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
58 EFSA Journal 2014;12(3):3599 
Hochmuth PS, 2000. KX-6145 Spray application to reduce bacterial pathogen contamination on 
poultry carcasses. From: Secondary direct additive petition: The use of peroxyacetic acid, octanoic 
acid, acetic acid, hydrogen peroxide, peroxyoctanoic acid and 1-hydroxyethylidene-1,1-
diphosphonic acid as an antimicrobial agent on poultry carcasses parts and poultry organs. Ecolab 
Inc.  
Humphreys PN, Finan P, Rout S, Hewitt J, Thistlethwaite P, Barnes S and Pilling S, 2013. A 
systematic evaluation of a peracetic-acid-based high performance disinfectant. Journal of Infection 
Prevention, 14(4), 126-131. 
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2004. 1-hydroxyethylidene-1-1-
diphosphonic acid. Compendium of food additive specifications. Addendum 12, 21-23.  
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2005. Peroxyacid antimicrobial 
solutions containing 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP). WHO Technical Report 
Series 928, 26-33.  
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2006. Peroxyacid antimicrobial 
solutions containing 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP). WHO Food Add. Series 
54, 87-115.  
Ma J, Yuan D, Guan B, Yang R and Ge L, 2007. Determination of 1-hydroxyethylidene-diphosphonic 
acid in recycle-cooling water by ion-chromatography. Se Pu, 25(2), 245-247. 
Mehyar G, Blank G, Han JH, Hydamaka A and Holley RA, 2005. Effectiveness of trisodium 
phosphate, lactic acid and commercial antimicrobials against pathogenic bacteria on chicken skin. 
Food Protection Trends, 25, 351-362. 
Miettinen O and Nurminen M, 1985. Comparative analysis of two rates. Stat Med, 4, 213-226. 
Møretrø T, Heir E, Nesse LL, Vestby LK and Langsrud S, 2012. Control of Salmonella in food related 
environments by chemical disinfection. Food Research International, 45(2), 532-544. 
Nagel GM, Bauermeister LJ, Bratcher CL, Singh M and McKee SR, 2013. Salmonella and 
Campylobacter reduction and quality characteristics of poultry carcasses treated with various 
antimicrobials in a post-chill immersion tank. International Journal of Food Microbiology, 165, 
281-286. 
Newcombe RG, 1998. Interval estimation for the difference between independent proportions: 
comparison of eleven methods. Stat Med, 17, 873-890. 
Nowack B, 1997. Determination of phosphonates in natural waters by ion-pair high-performance 
liquid chromatography. Journal of Chromatography A, 773, 139-146. 
Oste L, Mastalerz V, Keijzers R, van Herwijnen R, Janssen P, Fleuren R and Haverkamp T (Deltares), 
2009. Afleiding van 9 ad hoc MTR's 2008, 84 pp.  
PAR/Cefic Round Robin Test Procedure: Determination of Paracetic Acid. Accessed on: 2/25/2013.  
Rhee KS, Park J and Ziprin YA, 1989. Effects of Low Concentrations of H2o2 on Lipid Oxidation and 
of Storage and Ph on Nonheme Iron Content of Raw Beef Muscle. Journal of Food Biochemistry, 
13, 31-38. 
Rodrigues T and Howarth J, 2010. A field efficacy study using Perasan MP-2 for use as an 
antimicrobial agent In and On-line reprocessing systems for poultry applications. Enviro Tech 
Chemical Services, 24. 
Rodrigues T and Howarth J, 2011. Efficacy of 1100 ppm PAA (Perasan MP-2) and 335 ppm Br2 
(HB2) on Salmonella Heidelberg-Inoculated chicken halves. Enviro Tech.  
Rodrigues T, Mesrobian C and Howarth J, 2011. Efficacy of 500 ppm PAA (Perasan MP-2) on 
Salmonella Typhimurium and Campylobacter jejuni-Inoculated chicken halves. Enviro Tech.  
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
59 EFSA Journal 2014;12(3):3599 
Slump P and Schreuder HA, 1973. Oxidation of methionine and cystine in foods treated with 
hydrogen peroxide. J Sci Food Agric, 24, 657-661. 
Strange ED, 1984. Oxidation of Methionine in Model Systems. Journal of Agricultural and Food 
Chemistry, 32, 358-363. 
Thompson A, Abraham S and Rovison J, 2009. Reduction in Salmonella positives and microbial 
counts on chicken carcasses treated with 360 to 1800 ppm peracetic acid using Spectrum
TM
  in the 
finishing chiller to achieve USDA Category 1 status. International Association for Food Protection, 
96th Annual Meeting,  
Trevanich S, Tepsorn R, Vibulsresth P and Miyamoto T, 2003. Use of peroxyacetic acid to reduce 
multi-antimicrobial resistant Salmonella Virchow contamination in chicken meat.  
Vadhanasin S, Bangtrakulnonth A and Chidkrau T, 2004. Critical control points for monitoring 
salmonellae reduction in Thai commercial frozen broiler processing. Journal of Food Protection, 
67, 1480-1483. 
Verkaar E, 2006. Shelf life of packed broiler filets with respect to Senova/Inspexx treatment. Ecolab, 
8. 
 
  
Safety and efficacy of peroxyacids for decontamination of poultry carcasses 
 
 
60 EFSA Journal 2014;12(3):3599 
ABBREVIATIONS 
 
ADI  Acceptable Daily Intake 
ADI  Acceptable Daily Intake 
APC  Aerobic Plate Count 
BOD  Biological Oxygen Demand 
Bw  Body Weight 
CAS Chemical Abstracts Service 
CFU  Colony Forming Unit 
CI Confidence Interval 
EC European Commission 
ECB  European Chemical Bureau 
ECETOC  European Centre for Ecotoxicology and Toxicology of Chemicals 
EFSA  European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organisation of the United Nations 
FDA  Food and Drug Administration 
GHP  Good Hygienic Practices 
GRAS Generally Recognised As Safe 
HACCP  Hazard Analysis Critical Control Point 
HEDP 1-hydroxyethylidene-1,1-diphosphonic acid 
HERA  Human and Environmental Risk Assessment 
JECFA  Joint FAO/WHO  Expert Committee on Food additives 
LOD  Limit of Detection 
MDR Mean Decimal Reduction 
MoS  Margin of Safety 
NEC  No Effect Concentration  
NOAEL No Observed Adverse Effect Level 
NOEC No Observed Effect Concentration 
PAA Peroxyacetic acid 
PEC  Predicted Environmental Concentration 
RPR Relative Prevalence Reduction 
TBARS  Thiobarbituric Acid Reactive Substances 
WHO  World Health Organization 
 
